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Fresh sprouts have been responsible for 30 foodborne illness outbreaks and 1800 
cases since 1996 in the United States. Use of chemical sanitizers prior to the sprouting 
process has been attempted in many studies to decontaminate or control the growth of 
pathogens. In 1999, FDA issued a guidance to reduce microbial food safety hazards 
for sprouted seeds. However, even after FDA’s guidance, continuous outbreaks have 
still been a serious concern for consumers. 
In an attempt to control the growth of foodborne pathogens on sprouts using 
protective cultures, lactic acid bacteria (LAB) were isolated from fermented sprouts. 
Many of the LAB isolates were found to produce bacteriocins, which are ribosomally 
synthesized antimicrobial peptides that can inhibit closely related bacteria. One 
bacteriocin, designated mundticin L, produced by Enterococcus mundtii CUGF08 was 
found to inhibit Listeria spp. and other genera. Another bacteriocin, produced by 
Lactococcus lactis AA4 was found to be nisin Z. The genetic determinants for 
mundticin L, the associated ATP-binding cassette (ABC) transporter, and immunity 
protein were identified, cloned, and sequenced. Mundticin L was isolated and 
confirmed by N-terminal amino acid sequencing. The function of the immunity 
protein was analyzed by heterologous expression of the immunity gene in sensitive 
Gram-positive organisms. The immunity protein does not provide full protection. 
 However, additional factors may be involved in this unusual phenotype. Genomic 
mutagenesis may reveal these factors. 
Thermal inactivation and biological control utilizing naturally occurring 
bacteriocinogenic LAB were investigated as potential decontamination strategies. 
Both methods showed potential in enhancing the safety of fresh sprouts. LAB as 
bioprotective cultures to enhance the safety of sprouts may serve a model as a 
“natural” or “green” hurdle for the safety of non-fermented produce. 
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CHAPTER 1  
INTRODUCTION 
 
FOODBORNE ILLNESSES ASSOCIATED WITH FRESH PRODUCE 
Fruits and vegetables are an integral part of a daily diet. Besides their palatable taste, 
they may reduce the risks of chronic diseases including strokes, type 2 diabetes, some 
types of cancer, and possibly cardiovascular disease, and hypertension (16). They are 
usually low in calories and high in dietary fiber, vitamins and antioxidants, among 
other nutrients. The consumption of fresh produce has been increasing with the rising 
consumer awareness of health. 
However, consumption of fresh produce has raised a public health issue due to a 
series of foodborne illness outbreaks which implicated fresh produce as a vehicle for 
human pathogens. The number of illness outbreaks associated with fresh produce has 
been increasing. During 1973-1997, the proportion of produce-associated illness 
outbreaks in the United States increased from 0.7% in the 1970s to 6% in the 1990s 
(106). During the period of 1990-2005, the proportion of produce-associated outbreaks 
increased to the highest level at 13% (36). In addition, the total number of produce-
associated outbreaks has also increased. The increase in the number of outbreaks due 
to the consumption of fresh produce may be attributed to the following reasons: the 
rising consumption of fruits and vegetables during the past decades; the changing 
pattern in production and distribution of fresh produce, especially the globalization of 
the produce market with relatively localized strictness of agricultural and 
manufacturing practices; and the enhanced surveillance system for foodborne diseases, 
especially in the United States and Europe, which resulted in higher reported numbers 
of outbreaks than before (47). 
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During 1973-1997, Salmonella spp. was the most common pathogen associated 
with produce, followed by E. coli O157:H7, Shigella, and Campylobacter, while the 
most common virus was hepatitis A followed by norovirus. Cyclospora cayetanensis 
was the most frequent foodborne parasite associated with produce (106). However, 
during the period of 1990-2005, the most prevalent foodborne illness was attributed to 
norovirus infection while Salmonella spp. and E. coli O157:H7 remained as the 
primary etiological bacterial foodborne pathogens associated with foodborne illness 
(36). 
Salad, mixed fruits and vegetables accounted for approximately one third of all 
outbreaks and other single produce commodities were responsible for the remainder. 
Foodborne illness implicated single produce items include (in order of frequency for 
outbreaks) lettuce, melon, seed sprout, apple or orange juice, berries, tomato, green 
onion, carrot, apple, pear, pineapple, basil, celery, cucumber, fresh elderberry, and 
fresh-squeezed lemonade (106). Recently, spinach and jalepeno peppers joined this list 
after the notorious large multistate outbreaks due to consumption of spinach 
contaminated with E. coli O157:H7 in 2006 (20) and jalepeno peppers contaminated 
with Salmonella Saintpaul in 2008 (18). 
With the increasing number of produce-associated outbreaks, the relationship 
between pathogens and types of produce is being recognized, although scientific 
research on the molecular mechanism of how certain pathogens attach or colonize to 
specific produce has just started. Pathogen-food pairs are established based on the 
history of produce-associated outbreaks; for example, Salmonella spp. from sprouts, 
melons, tomatoes, peppers, orange juice; E. coli O157:H7 from leafy greens, apple 
juice/cider and sprouts. The relationship between pathogens and produce is influenced 
by many factors, including the nature of the surface for attachment/colonization and 
the bacterial strain itself. For example, a recent genomic analysis of the E. coli 
  3 
O157:H7 strain that was associated with the 2006 spinach outbreak revealed a unique 
DNA fragment that contains genes for enhanced virulence and adaptation to plants 
(75). However, no conclusive mechanism has been established to elucidate the 
colonization of human pathogens on plant surfaces although it is recognized that 
strains even within the same species vary in their ability to colonize plant surfaces and 
pathogens can be internalized into the tissue of fresh produce which renders surface 
disinfectants unreliable for eliminating pathogens (117). 
The source of contamination depends on the specific pathogen. Salmonella spp., E. 
coli O157:H7, Shigella spp. and Campylobacter spp. are natural inhabitants in animal 
or human hosts. For Salmonella spp. and Campylobacter spp., avians are the primary 
reservoir and vehicle, while for E. coli O157:H7, bovine are the most common carriers. 
Humans are the natural reservoir for Shigella spp. Fresh produce can be contaminated 
with foodborne pathogens at any point in the chain from farm to table. Therefore, it is 
not surprising that waste and manure shed from domestic or wild animals in the field 
is a dominant route for E. coli O157:H7 and Salmonella spp. contamination while the 
majority of shigellosis outbreaks have been attributed to direct fecal contamination by 
food handlers with poor hygiene practices. Post-harvest cross-contamination in food 
processing plants and food catering kitchens are additional potential risks for all 
foodborne pathogens. 
Although various factors as mentioned above could play a role in the emerging 
illness outbreaks associated with produce consumption, pre-harvest contamination in 
the field has been the primary cause. The initial microbial load on produce is due to 
pre-harvest contamination (pathogenic and non-pathogenic microorganisms) during 
growing. The initial microbial load on the produce influences how effective the 
downstream (post-harvest) antimicrobial processing and treatments will be. Once 
contaminated animal manure or runoff from livestock farm is released to the 
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environment, E. coli O157:H7 and Salmonella spp. may survive in soil for months (48, 
49, 104). Moreover, the rhizosphere of plants in soil was found to enhance the survival 
of E. coli O157:H7 for even longer times (49, 59). The surviving pathogens can 
contaminate fresh crops directly or indirectly. Pathogens from untreated manure can 
contaminate irrigation water which in turn may contaminate the rhizosphere or 
phyllosphere of the growing plants.  
A systematic approach is needed to control pre-harvest and post-harvest 
contamination. This approach requires involvement of research institutions and 
regulatory agencies to assess potential alleviation or decontamination methods and 
incorporate these novel methods into regulatory intervention programs such as Good 
Agriculture Practices (GAP), Good Manufacturing Practices (GMP) and Hazard 
Analysis and Critical Control Points (HACCP) to protect the food supply. The 
effectiveness of these process control strategies has been proven for specific food 
commodities. For example, the number of outbreaks associated with juice has been 
significantly reduced according to CDC reports since FDA implemented the Juice 
HACCP regulation (CFR 120.20) that required a juice HACCP plan and the 5-log 
reduction performance standard (120).  
A SPECIAL CONCERN WITH ALFALFA SPROUTS AND INTERVENTION METHODS FOR 
DECONTAMINATION 
Fresh sprouts are considered as a healthy food that is low in calories and rich in 
dietary fiber and phytoestrogens that may prevent menopausal symptoms, osteoporosis, 
cancer and heart disease (76). Fresh sprouts are widely consumed raw or lightly 
cooked as in salads, sandwiches, hamburgers, etc. However, they are notorious for 
being a food vehicle for human pathogens such as Salmonella spp. and E. coli 
O157:H7. Table 1.1 is an updated list of foodborne illness outbreaks associated with 
fresh sprouts. 
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Table 1.1. List of foodborne illness outbreaks associated with fresh sprouts. 
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Year Pathogen Cases Country Type of sprout 
1976 Bacillus cereus 4 U.S. Vegetable 
1982 Y. enterocolitica 16 U.S. Mung bean 
1988 
S. Saintpaul, S. Havana, S. 
Muenchen 
148 Sweden Mung bean 
1988 S. Saintpaul, S. Virchow 150 U.K. Mung bean 
1989 S. Gold-Coast 31 U.K. Cress 
1990 S. Anatum 15 U.S. Alfalfa 
1992 S. enterica 272 Finland Alfalfa 
1994 S. Bovismordificans 492 Finland, Sweden Alfalfa 
1995 S. Stanley 242 Finland, U.S. Alfalfa 
1995 S. Newport 154 Denmark Alfalfa 
1995/96 S. Newport 133 
U.S., Canada, 
Denmark 
Alfalfa 
1996 E. coli O157:H7 5,853 Japan Radish 
1996 
S. Montevideo and S. 
Meleagridis 
492 U.S. Alfalfa 
1997 S. Anatum and S. Infantis 109 U.S. Alfalfa 
1997 E. coli O157:H7 187 U.S. Alfalfa 
1997 S. Meleagridis 78 Canada Alfalfa 
1997/98 S. Senftenberg 60 U.S. Alfalfa 
1998 S. Havana and S. Cubana 40 U.S. Alfalfa 
1998 E. coli O157:H7 8 U.S. Alfalfa, clover 
1999 
S. Mbandaka, S. Muenchen, 
S. Typhimurium 
>352 U.S. Alfalfa 
1999 S. Saintpaul 36 U.S. Clover 
1999 S. paratyphi var Java 51 Canada Alfalfa 
2000 Salmonella spp.,  22 U.S. Alfalfa 
2000 S. Enteritidis PT 4b 27 Netherlands Mung bean 
2000 S. Enteritidis 75 U.S. Mung bean 
2001 S. Enteritidis PT 913 84 Canada Mung bean 
2001 S. Enteritidis 35 U.S. Mung bean 
2001 S. Kottbus 32 U.S. Alfalfa 
2002 S. Enteritidis NA U.S. Mung bean 
2002 E. coli O157:H7 5 U.S. Alfalfa 
2003 E. coli O157:H7 7 U.S. Alfalfa 
2003 E. coli O157:NM (H-) 13 U.S. Alfalfa 
2003 S. Chester, S. Saintpaul 42 U.S. Alfalfa 
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Table 1.1 (continued) 
 
2002 S. Enteritidis NA U.S. Mung bean 
2002 E. coli O157:H7 5 U.S. Alfalfa 
2003 E. coli O157:H7 7 U.S. Alfalfa 
2003 E. coli O157:NM (H-) 13 U.S. Alfalfa 
2003 S. Chester, S. Saintpaul 42 U.S. Alfalfa 
2004 E. coli O157:H7 2 U.S. Alfalfa 
2004 S. Bovismordificans 35 U.S. alfalfa 
2005 S. Enteritidis PT 13 552 Canada Mung bean 
2006 Salmonella spp. >100 Australia Alfalfa 
2006 S. Bareilly or S. Virchow 115 Sweden Mung bean 
2006 S. Braenderup 4 U.S. Bean 
2007 S.  Stanley 51 Sweden Alfalfa 
2007 S. Weltevreden 45 
Norway, 
Denmark, 
Finland 
Alfalfa 
2007 S. Mbandaka 15 U.S. Alfalfa 
2007 S. Montevideo 24 U.S. Bean 
2009 S. Saintpaul 228 U.S. Alfalfa 
 
Note: This list is compiled from a summary report from Food Standards Agency (46) and other 
governmental or institutional sources (17, 19, 21-25, 33, 39, 43, 94, 96, 125, 126). 
 
The majority of the outbreaks were due to Salmonella spp. and the most implicated 
type of sprouts was alfalfa sprouts. Fresh sprouts, especially alfalfa sprouts represent 
such a dangerous health risk for consumers, that in 1999 the FDA started to issue a 
warning that “those persons who wish to reduce the risk of foodborne illness from 
sprouts are advised not to eat raw sprouts” (118). It was a result of clustered foodborne 
outbreaks associated with consumption of fresh sprouts since 1995 (Table 1.1). Table 
1.1 indicates that the most common pathogen for sprout illness outbreaks is 
Salmonella spp., followed by E. coli O157:H7 and other less frequently associated 
pathogens. The most commonly implicated type of sprouts is alfalfa sprouts, followed 
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by mung bean sprouts. Listeria monocytogenes has been detected in alfalfa sprouts and 
resulted in multiple food recalls although outbreaks linked to Listeria monocytogenes 
contamination have not been reported. One study demonstrated that Listeria 
monocytogenes can rapidly grow to high levels during the sprouting process (89). The 
potential risk of listeriosis from consumption of fresh sprouts can not be 
underestimated due to its high fatality rate and zero tolerance for L. monocytogenes 
contamination level in many countries, including the United States.  
Contaminated seeds are the primary source for most sprout-associated outbreaks 
(82), i.e., the seeds were contaminated with Salmonella spp. and/or E. coli O157:H7 in 
the growing field, although contamination during production, processing, packaging, 
distribution and preparation may also have occurred. The contamination level present 
on the seeds was found to be very low. It was estimated that Salmonella spp. existed 
on naturally contaminated seeds at levels lower than 1-6 CFU/100g seeds (82). 
Although the number of pathogenic cells on seeds do not exceed the infective dose for 
Salmonella spp. and E. coli O157:H7, the conditions used for sprouting (~25°C for 3 
or more days with humidity and nutrients released from young sprouts) provide an 
optimal incubation for the growth of bacterial foodborne pathogens. The pathogenic 
cells on naturally contaminated seeds can grow to high levels (111), amplifying the 
risk of pathogen infection after consumption of the finished sprouts. 
Due to the fact that the seeds are contaminated at the pre-harvest stage, the most 
feasible intervention strategy to control the risk of the outgrowth of foodborne 
pathogens is to decontaminate the seeds prior to sprouting so that pathogens will not 
have a chance to multiply during the sprouting process. However, alfalfa seeds have 
been found to be difficult to decontaminate due to their special seed structures, such as 
wrinkles and crevices on the surface of seeds, that can protect pathogens from being 
accessed by surface sanitizers (26). A number of disinfection methods have been 
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investigated in an attempt to decontaminate seeds. The diversity of the methods 
investigated for their potential in improving the safety of sprouted seeds was a display 
of most, if not all, of antimicrobial approaches that already existed in modern food 
microbiology. These treatments include physical, chemical and biological strategies. 
Physical treatments include irradiation, heat and pressure. Irradiation treatments were 
reported to inactivate Salmonella spp. and E. coli O157:H7 by less than 5 logs; 
however, irradiation reduced the germination and yield of sprouts (for example, length 
of sprouts) especially when the dose exceeded 2 kGy (6, 97-99, 102, 116). Heat 
treatment has an advantage of being able to inactivate pathogens trapped in crevices 
and winkles which are physical barriers for chemical sanitizers. Wet heat treatment at 
high temperatures for relatively short times as a sole treatment was found to be 
effective in achieving a 5-log reduction on seed types other than alfalfa seeds without 
affecting seed viability, but the viability of alfalfa seeds was more easily reduced (5, 
121, 122). It is known that seeds can tolerate dry heat treatment which has been shown 
to be a promising approach for mung bean seeds (57). High hydrostatic pressure 
especially in combination with mild heat was reported to be effective in eliminating 5-
logs of E. coli O157:H7 populations on alfalfa seeds without significantly affecting 
seed viability (83-85). Chemical treatments of seeds using hypochlorite, trisodium 
phosphate, chlorine dioxide, hydrogen peroxide, calcium hydroxide, lactic acid, citric 
acid, acetic acid, fatty acids, allyl isothiocyanate, ammonium (9-11, 55, 61, 90, 92, 
103, 115, 123, 124) have been investigated for their effectiveness in decontamination 
of experimentally inoculated alfalfa seeds. However, none of these methods were 
capable of achieving a 5-log reduction in pathogen populations without negatively 
affecting seed viability or causing organoleptic defects in the finished sprouts. 
Salmonella spp. and E. coli O157:H7 commonly have been recovered or detected after 
treatments by enrichment culturing, suggesting that elimination of pathogens in seeds, 
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in order to prevent multiplication of surviving cells, is not possible by these chemical 
treatments. Among these chemicals, hypochlorite attracted attention for its efficacy in 
reducing pathogens on seeds without reducing seed viability. In 1999, after a cluster of 
foodborne illness outbreaks over a 3-year period, FDA issued two guidance 
documents to the sprout industry: “Reducing Microbial Food Safety Hazards for 
Sprouted Seeds” and “Sampling and Microbial Testing of Spent Irrigation Water 
during Sprout Production”. The former recommends that seeds be soaked in 20,000 
ppm calcium hypochlorite for 15 min as a single treatment step prior to sprouting 
while the latter advises that spent irrigation water be sampled for microbial testing as 
an indicator for contamination of sprouts. 
Unfortunately, outbreaks continued to occur after FDA’s recommendations. 
Investigations revealed that outbreaks were linked to sprouted seeds that were 
pretreated following FDA’s guidance (95). Based on subsequent outbreaks, it is 
evident that a single-step treatment with surface sanitizer can not sufficiently eliminate 
pathogens in seeds, and thus prevent the outgrowth of pathogens during sprouting.  
New intervention methods that are capable of eliminating pathogens in seeds and/or 
control the growth of pathogens during sprouting are needed to enhance the safety of 
alfalfa sprouts. As mentioned above, thermal inactivation may have potential due to its 
effectiveness regardless of seed structure. Biological control utilizing protective 
cultures, particularly food-grade lactic acid bacteria, may be another promising 
strategy to inhibit the growth of pathogens during sprouting. 
LACTIC ACID BACTERIA AS BIOLOGICAL CONTROL AGENTS 
Lactic acid bacteria (LAB) are a diverse group of Gram-positive, non-sporulating 
and non-respiring cocci or rods whose main end product of metabolism is lactic acid 
(101). The delimitation of lactic acid bacteria has been a controversy since some 
genera such as Listeria and Bacillus that are not traditionally considered as LAB can 
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produce lactic acid. However, it is generally agreed that the LAB group includes 
Lactococcus, Lactobacillus, Leuconostoc, Streptococcus, Enterococcus, Pediococcus, 
Oenococcus, Aerococcus, Carnobacterium, Tetragenococcus, Weisella and 
Vagococcus (113). The genomes of LAB are mostly AT-rich and contain less than 
50% GC (129). Lactic fermentation by LAB started to be an integral part of food 
production in the history even before humans recognized their role. Besides the flavors 
LAB fermentations afford, LAB fermentation serves as a preservation method for 
foods that otherwise would be perishable within a shorter shelf life. LAB are known as 
starter cultures in fermentations to produce milk products such as yogurt and cheese, 
meat products such as sausage and hams, vegetables and fruits such as sauerkraut and 
pickles and wines. Members of LAB have been identified to be probiotics that are 
“live microorganisms, which when consumed in adequate amount, confer a health 
benefit on the host” (93). The health benefits include alleviation of disorders in 
gastrointestinal tract, improved immune system and prevention of certain chronic 
disease and cancer although the molecular mechanisms for those benefits were not 
clear (93). 
The protective properties of LAB in foods have been recognized and attracted great 
attention from scientists. With consumers’ rising dietary awareness and their demand 
for more “natural” or “green” technologies used in food processing, chemical 
preservatives have become a public concern due to their variable toxicity and side 
effects to humans. The increasing consumption of fresh produce and minimally 
processed foods challenges conventional preservation methods, and the use of non-
thermal and natural strategies as alternative preserving methods has been examined for 
their feasibility to meet consumer demands while guaranteeing food safety. LAB 
produce lactic acid and other organic acids, reuterin, hydrogen peroxide, and 
bacteriocins which are ribosomally synthesized peptides that can inhibit closely 
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related bacteria (66). Besides the antimicrobial compounds that LAB produce, the 
growth of LAB themselves is a competitive exclusion of other spoilage and 
pathogenic microflora that otherwise may grow to high levels, resulting in shorter 
shelf life or foodborne illness. LAB may be directly applied into food systems without 
approval from FDA because the majority of LAB are generally recognized as safe 
(GRAS). Because of the GRAS status, LAB and their metabolites are all considered to 
be “green, safe and natural”. However, purified compounds such as bacteriocins that 
are produced by LAB are subject to FDA approval because it is considered as an 
additive. Therefore, application of live LAB cultures rather than their metabolites in 
food systems to extend shelf life and improve food safety is a promising alternative 
without extensive regulatory involvement for application. 
Many studies in biopreservation using LAB have been directed at controlling 
pathogens in meat products, especially vacuum-packed meats, sausages, raw meats 
and cooked meats. Listeria monocytogenes is the primary pathogen of concern in 
cooked meats, whereas post-processing contamination by Listeria monocytogenes has 
been responsible for numerous outbreaks. Sausages pose a food safety concern with 
contamination and survival of Listeria monocytogenes since they are not cooked and 
Listeria monocytogenes is capable of growing at refrigeration temperatures. Another 
pathogen that poses food safety concern especially in vacuum-packed or modified-
atmosphere-packed products is Clostridium botulinum, which can produce deadly 
neurotoxins in foods. Therefore, many studies have investigated the use of LAB to 
control these two pathogens in meat products. E. coli O157:H7 and Salmonella spp. 
are also potential pathogens with meat and meat products but fewer studies using LAB 
as biocontrol cultures have been performed. Since LAB are part of the natural 
microflora in meats and even dominate certain foods, screening for protective strains 
from their natural microbiota is a good strategy (112). Criteria for screening include 
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their growth rate in select food systems, acid production, bacteriocin production and 
their inhibitory activity against target pathogens or spoilage organisms. 
Bacteriocinogenic LAB have attracted much attention due to their inhibitory activity 
against Listeria monocytogenes, in addition to antimicrobial effects of decreased pH, 
hydrogen peroxide and competition for growth. Nisin-producing Lactococcus lactis 
subsp. lactis has been extensively studied because nisin can inhibit both Listeria 
monocytogenes and Clostridium botulinum while pediocin-producing Pediococcus 
acidilactici was used to inhibit Listeria monocytogenes due to the higher antimicrobial 
activity of pediocin. In general, bacteriocinogenic LAB were shown to be promising 
candidates for controlling the growth of pathogens such as Listeria monocytogenes 
and Clostridium botulinum. Inhibition of Gram-negative pathogens such as E. coli 
O157:H7 and Salmonella spp. is primarily due to the acids that LAB produced and to 
a lesser extent, their competitive exclusion (72). 
Research in biological control of pathogens in fresh produce is just in its early 
stages. While bacteriocinogenic LAB are known to play an important role in 
preserving fermented vegetables such as olives, sourdough, miso and sauerkraut, their 
potential role in protecting non-fermented vegetables has yet to be fully investigated 
(105). Non-bacteriocinogenic Lactococcus lactis isolated from alfalfa sprouts were 
studied for its inhibitory activity against Listeria monocytogenes on alfalfa sprouts. It 
was found that although Lactococcus lactis showed some inhibition against Listeria 
monocytogenes during sprouting compared to the control, Listeria monocytogenes was 
shown to still be able to grow into high levels (89). Cai and his co-workers isolated 
bacteriocin-producing L. lactis subsp. lactis and Enterococcus faecium strains from 
mung bean sprouts and applied these strain to Caesar salad to control the growth of L. 
monocytogenes (15). Both bacteriocinogenic LAB inhibited L. monocytogenes in 
salads compared to the control; however, when the salad was co-inoculated with both 
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strains, no synergic effect was observed. Lactococcus lactis displayed a stronger 
inhibitory effect than E. faecium. Bennik and co-workers (7) isolated mundticin-
producing Enterococcus mundtii ATO6 and pediocin-producing Pediococcus parvulus 
from chicory endive. E. mundtii ATO6 was able to produce mundticin at refrigeration 
temperatures. Although both strains showed inhibition on L. monocytogenes in model 
medium systems, they did not inhibit the growth of L. monocytogenes on fresh mung 
bean sprouts stored under modified atmosphere at 8°C. Few studies have investigated 
the potential antagonistic effect of LAB on Gram-negative pathogens such as E. coli 
O157:H7 and Salmonella spp. which are the pertinent pathogens for sprout-associated 
outbreaks. L. lactis subsp. lactis and Pediococcus acidilactici isolated from alfalfa 
seeds were tested for their inhibition on Salmonella spp., E. coli O157:H7 and L. 
monocytogenes (127). Both strains demonstrated significant antagonistic properties 
against these pathogens; unfortunately, the study was performed in MRS broth rather 
than fresh sprouts. Pseudomonas fluorescens 2-79 was shown to effectively inhibit the 
growth of Salmonella spp. during sprouting of alfalfa seeds (44). Although 
Pseudomonas spp. are known members of the indigenous microflora on fresh sprouts, 
artificial level of pseudomonads as biocontrol agents in foods may be a controversial 
issue due to their non-food-grade status. 
AN UPDATED REVIEW OF BACTERIOCINS: THEIR CLASSIFICATION, BIOSYNTHESIS, 
REGULATION, IMMUNITY, RESISTANCE, MODE OF ACTION AND ANTIMICROBIAL 
SPECTRUM 
Bacteriocins are ribosomally synthesized proteinaceous compounds that inhibit 
closely related bacteria (66). Although scientific attention has been directed at 
bacteriocins produced by Gram-positive LAB due to their promising applications in 
foods, “bacteriocin” was coined for colicin which was the first discovered bacteriocin 
from E. coli (30). Mankind has benefited from bacteriocins produced in situ by 
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indigenous LAB microflora since the discovery of fermented foods. However, 
deliberate use of bacteriocins emerged only five decades ago when nisin was first 
marketed in England. Nisin was officially approved for use as a food additive in 1988 
by the U.S. FDA. Scientists have been focusing on isolation, characterization and 
application of bacteriocins in food systems. Novel bacteriocins continue to be 
discovered and added to the long list of known bacteriocins. Discovery of bacteriocins 
has been the result of mostly phenotypic observations by inhibition assays in microbial 
media. The advancement of nucleotide sequencing technologies has made high 
throughput genome-sequencing of microorganisms more achievable in terms of cost 
and time. Genome-wide data mining may be a powerful tool to find open reading 
frames that encode novel bacteriocins which would be difficult to be revealed by 
traditional phenotype-based assays (91). Genomics of lactic acid bacteria will 
accelerate the discovery of bacteriocins, especially for those whose production is 
conditional; more and more bacteriocins are being determined to be produced only by 
induction by a cell-density-dependent signal peptide (quorum sensing). 
Bacteriocins, their genetic organization, biosynthesis, classification, characteristics 
and application in various foods have been reviewed extensively by many researchers 
(29, 30, 38, 41, 50, 60, 66, 86, 105, 128). Therefore, an updated, rather than a 
comprehensive review will be given here. Some areas which other reviews did not 
cover will be discussed more in depth. 
Classification of bacteriocins. Bacteriocins are classified into three main classes. 
Klaenhammer (66) proposed that bacteriocins be divided into four distinct classes: 
class I, lantibiotics containing post-translationally modified amino acids such as 
lanthionine, β-methyllanthionine and dehydrated residues; class II, consisting of small, 
heat-stable and unmodified peptides; class III, bacteriocins which are large heat-labile 
proteins; class IV, containing complex bacteriocins which requires chemical moieties 
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such as lipid and carbohydrate for activity. The classification scheme changed with 
newly identified bacteriocins challenging the existing knowledge. Class IV as an 
independent group was controversial and questioned due to the lack of scientific 
information about these bacteriocins and to the later finding that the claimed loss in 
activity of the peptide moiety might be the result of purification artifact (62, 86). 
Cotter (30) proposed a modified scheme for three classes, with class III assigned for 
bacteriolysins as non-bacteriocin lytic proteins which can hydrolyze cell walls of 
target organisms and may not have dedicated immunity proteins. However, class III 
should be excluded from the bacteriocin classification, considering the limited 
application in foods, and the differences in molecular structure and genetic 
organization. 
Class I bacteriocins are a group of modified peptides that are so diverse in structure, 
biosynthesis and amino acid sequence that sub-classification into smaller groups is 
difficult although some researchers proposed subclasses (38, 128). The most important 
structural feature is that they contain modified amino acids. Amino acids with a 
hydroxyl group may be dehydrated by dehydratase. For example, serine and threonine 
in nisin may be dehydrated into didehydroalanine (Dha) and didehydrobutyrine (Dhb), 
respectively. The sulfhydryl group of cysteine can react with the double bonds in Dha 
and Dhb to form lanthionine and β-methyllanthionine, respectively. Since the reaction 
may occur between cysteine and Dha/Dhb that could be distant in primary structure, 
the resultant modified amino acids produce structural rings which are believed to play 
an important role in the antimicrobial activity of lantibiotics.  
Class II bacteriocins are small, heat-stable and unmodified peptides that may be 
divided into three or four subclasses. Klaenhammer (66) proposed that class II 
bacteriocins be divided into three subclasses: Class IIa containing Listeria-active 
peptides with a N-terminus of Tyr-Gly-Asn-Gly-Val-Xaa-Cys motif; class IIb of two-
  17 
peptide bacteriocins; class IIc of thio-activated peptides. This scheme did not indicate 
the true distinctiveness of different class II bacteriocins in terms of their primary 
structure, function and antimicrobial spectrum. Also, these subclasses could not 
accommodate all class II bacteriocins that were subsequently found. Cotter (30) 
proposed that class II bacteriocins be divided into four subclasses: class IIa of 
pediocin-like bacteriocins which is the same group proposed by Klaenhammer; class 
IIb of two-peptide bacteriocins; class IIc of cyclic bacteriocins; and class IId of non-
pediocin linear peptides. Drider (38) divided the class II bacteriocins into three 
subclasses: class IIa of pediocin-like bacteriocins; class IIb of two-peptide bacteriocins; 
class IIc of other bacteriocins. All the schemes for classification agreed that pediocin-
like bacteriocins with a conserved N-terminus of YGNGV and two-peptide 
bacteriocins be separate subclasses. However, opinions differed about whether the 
cyclic peptides should be separated from other miscellaneous peptides. With more and 
more class II bacteriocins being discovered, the information on the structure of 
bacteriocins and their function would be sufficient for a clearer and open-ended 
classification. For convenience, the following discussions adopt the classification 
scheme proposed by Cotter (30). 
Genetics of biosynthesis and regulation. Production of bacteriocins requires genes 
for a dedicated transporter protein that may have protease activity to cleave the 
precursor peptide and for immunity proteins that protect the producer organisms 
against their own bacteriocins. The genetic organization is different depending on 
which class of bacteriocins. The genetic organization of class I bacteriocins is more 
complex than that of class II bacteriocins because class I bacteriocins require enzymes 
for post-translational modifications. The molecular mechanism for immunity is also 
more complex. Immunity to nisin requires more than one protein which is sufficient 
for immunity in class II bacteriocins. 
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The structural gene for nisin encodes a 57-residue precursor with 23 residues for its 
leader peptide and 34 residues for the mature bacteriocin. The primary structure of 
nisin is highly homologous to subtilin and epidermin (14). Eleven genes have been 
identified for nisin production (73, 74). These genes are clustered in the chromosome 
of L. lactis. NisA encodes nisin A precursor. Downstream genes following NisA are 
NisBTCIPRKFEG. NisB and NisC are membrane-associated proteins that are 
responsible for nisin modification and maturation (40). NisT is a dedicated transporter 
for NisA. NisP is a protease that cleaves the nisin precursor so that the mature 
bacteriocin is released to extracellular environment for its antimicrobial function. NisI 
and NisFEG are proteins believed to be involved in producer immunity to nisin. NisR 
and NisK are regulatory proteins for nisin biosynthesis. Nisin is an auto-regulator of 
its own biosynthesis. The producer organism can quorum-sense extracellular level of 
the fully modified and mature bacteriocin through a two-component regulatory system 
consisting of proteins NisK and NisR (74). The membrane-associated histidine kinase 
(NisK) senses extracellular nisin molecules and activates the response regulator 
(NisR). The response regulator can activate transcription of the nisin gene and other 
genes in the same operon. The nisin-inducible expression system has been attracting 
scientific attention due to its potential use for overproduction of proteins and 
nutraceuticals that have industrial and therapeutic values. Products of interest were 
shown to be overproduced in L. lactis strains on the condition of nisin being added as 
an inducer (34). The gene for β-glucuronidase as a reporter protein was fused to the 
promoter elements of the nisin gene and NisK/NisR were expressed independently in 
the cell. A dual-plasmid expression system was developed for homologous 
overproduction in L. lactis and heterologous expression in Leuconostoc lactis and 
Lactobacillus helveticus (68).  
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It had been considered for a long time that the genes for nisin were organized in 
three operons: NisABTCIP, NisRK and NisFEG. However, it would be difficult to 
explain how the producer organism L. lactis can produce sufficient immunity protein 
NisI to protect itself from being killed before nisin is produced since the genes for 
NisA and NisI were in the same operon and expression of both requires induction by 
extracellular nisin. A recent study found the existence of an internal promoter for 
transcription of NisI and NisP (77), suggesting that the expression of NisI and NisP 
may not completely depend on induction by the pre-existing nisin so that immunity 
can establish in the producer before nisin can be produced to bactericidal levels. 
The structural gene for subtilin precursor encodes 56 amino acids with 24 residues 
for the leader peptide and 32 residues for the mature subtilin (4). Although subtilin is 
produced by Bacillus subtilis which is in a different genus, the structure of subtilin is 
similar to that of nisin. Both peptides contain five intramolecular thio-rings at the 
same residues. The genetic organization for subtilin is also similar to that for nisin (4, 
42, 69-71, 109). Related genes encode proteins that are similar to those for nisin: 
SpaBTC to NisBTC, SpaIFEG to NisIFEG and SpaRK to NisRK. However, the 
location of the subtilin structural gene is unique. It is contained in the middle of the 
gene cluster while the nisin structural gene is the first open reading frame in the cluster. 
Also, genes SpaIFEG encoding immunity proteins for subtilin are clustered in a single 
operon while NisI and NisFEG are separated to two operons. The protease encoded by 
NisP which cleaves the nisin precursor is absent in the gene cluster of subtilin. Instead, 
the subtilin precursor is cleaved by an unspecific serine protease secreted by B. subtilis. 
Similarly, the biosynthesis of subtilin is regulated by quorum-sensing subtilin itself 
through a histidine kinase/response regulator two-component system encoded by SpaK 
and SpaR (67).  
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Genetic organization and biosynthesis varies among other lantibiotics such as 
lacticin 481, lacticin 3147, epidermin, pep5, cinnamycin, mersacidin, cytolysin and 
sapB (128). Production of cytolycin was also found to be auto-regulatory by a two-
component regulatory system (54). No lantibiotics other than nisin, subtilin and 
cytolysin were shown to be the signaling molecules for their own biosynthesis thus far. 
Different from class I bacteriocins which are mostly chromosome-associated, the 
majority of class IIa bacteriocins are plasmid-encoded with the exceptions of enterocin 
A, divercin V41, sakacin P, carbobacteriocins B2 and BM1 (38). Class IIa bacteriocins 
are a prominent group due to their Listeria-specific antimicrobial activity and their 
distinctive structural features such as a highly conserved YGNGV motif in the N-
terminus of the mature bacteriocins and a double glycine cleavage site in the leader 
peptides. Usually 2-4 genes are clustered closely in one or multiple operons for 
biosynthesis. The first fully characterized bacteriocin in this group is pediocin PA-1 
(79). Four open reading frames were discovered for biosynthesis of pediocin PA-1. All 
four genes are clustered in one operon. The first gene PedA encodes the pediocin PA-1 
precursor, followed by the second gene PedB for immunity, the third and forth genes 
PedC and PedD for an accessory protein for processing the precursor and for an ATP 
binding cassette (ABC) transporter, respectively (119). However, biosynthesis of 
enterocin P only requires two genes, one encoding the enterocin P precursor and the 
other one encoding the immunity protein. Genes encoding maturation- and transport-
related proteins are missing in the locus of enterocin P. This type of bacteriocin relies 
on the general sec-pathway for bacteriocin maturation and transport (28). The leader 
peptide of enterocin P is highly homologous to sec-dependent signal peptides, 
suggesting that enterocin P is exported by the general sec-pathway. Biosynthesis of 
some bacteriocins requires more than four genes. Fore example, enterocin A (3, 87), 
sakacins A and P (2, 58) and divercin V41 (80) require additional genes encoding a 
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three-component regulatory system that controls biosynthesis by quorum-sensing an 
exported induction peptide. The three component genes which usually are contained in 
the upstream region of the bacteriocin structural gene, encode an induction peptide, a 
histidine kinase and a response regulator. The induction peptide acts as a cell-density 
signal that may activate the kinase by phosphorylation which in turn activates the 
response regulator by transphosphorylation. The activated response regulator can up-
regulate the transcription of the bacteriocin genes including the structural gene. The 
biosynthesis of class IIa bacteriocins is regulated in a similar manner compared to the 
class I bacteriocins. The difference is that the production of class IIa bacteriocins is 
inducible by peptides that are different in sequence from the bacteriocins, while class I 
bacteriocins such as nisin and subtilin are autoinducers themselves. The induction 
peptides for class IIa bacteriocins are produced as prepeptides in cells before 
maturation. It should be noted that only part of class IIa bacteriocins have three-
component regulatory system; i.e. most class IIa bacteriocins are produced 
constitutively. Besides bacteriocins whose production requires 2, 4 or more than 4 
genes, the recently identified mundticins indicated that three genes are sufficient for 
production (8, 65, 100). Three genes for mundticins are clustered in two operons with 
the structural gene in the first operon and the genes for the ABC transporter and the 
immunity protein in the second operon. The genetic organization for mundticins is 
different from other class IIa bacteriocins whose structural genes are usually clustered 
together with the immunity gene in the same operon. 
Two-peptide bacteriocins are classified as class IIb. Both peptides are required for 
functioning of their antimicrobial activity although either one of the peptides may 
have low activity. The genetic organization of two-peptide bacteriocins are similar to 
class IIa bacteriocins: two structural genes encoding two peptide precursors, one gene 
encoding an immunity protein, two genes encoding an accessory protein whose 
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function is not well know and an ABC transporter. Therefore, five genes are the 
minimum for biosynthesis of two-peptide bacteriocins (88). Similarly, production of 
some members of class IIb bacteriocins is regulated by three-component regulatory 
system which has been described above for class IIa bacteriocins. 
Class IIc consists of circular bacteriocins. The N and C termini of the peptides are 
connected by a peptide bond. Although only a few bacteriocins in this group have 
been identified, the genetic organization of those well characterized bacteriocins, is 
similar to other groups of class II bacteriocins. However, most bacteriocins are 
chromosome-encoded except for acidocin B and enterocin AS-48 whose genes are 
located in plasmids (78). Their genes are organized in multiple operons encoding the 
bacteriocin precursors and proteins for processing, transport, immunity and regulation. 
Although many bacteriocins in this group are produced constitutively, operons for 
circularin A contain genes encoding a histidine kinase and a response regulator which 
may be involved in regulation of biosynthesis. 
Class IId consists of non-pediocin-like “miscellaneous” bacteriocins that do not 
have sequence similarity to other bacteriocins. These bacteriocins have narrower 
antimicrobial spectrum than other bacteriocins. For example, lactococcin A is only 
inhibitory against Lactococcus spp. (56, 114); the antimicrobial spectrum of divergicin 
A is similarly narrow (130). Only two genes are required for biosynthesis of divergicin 
A: one encoding divergicin A precursor and the other one encoding an immunity 
protein. These two genes are clustered closely in one plasmid-associated operon. The 
leader peptide of divergicin A is a homologue to sec-dependent leaders. Heterologous 
expression of divergicin A implied that two genes are sufficient for production. Unlike 
divergicin A, genes for lactococcin A include two additional genes: a gene encoding 
the ABC transporter-like protein and a downstream gene encoding a protein that might 
be related to secretion. 
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Immunity and resistance. Although immunity and resistance to bacteriocins are 
combined for discussion here, they are fundamentally different concepts in the context 
of bacteriocins. Immunity refers to the mechanism that the bacteriocin-producing 
microorganisms use to protect themselves from being killed by their own bacteriocins. 
Resistance to bacteriocins refers to the development of insensitivity in originally 
sensitive microorganisms. 
Combinational expression of genes for NisI, NisF, NisE and NisG in heterologous 
and sensitive Bacillus subtilis indicated that either NisI or NisFEG confer protection 
against nisin (107). However, coordinated expression of all four genes provided 
strongest immunity to nisin, suggesting NisI and NisFEG are playing roles in self-
immunity of the nisin producer L. lactis. Studies showed that subtilin immunity 
proteins SpaIFEG function in a manner that is similar to that of nisin (108). Although 
high similarity in genetics and mechanism exists in nisin- and subtilin-producers, 
cross-immunity was not observed. Most of other lantibiotic-producers also rely on 
similar mechanism for self-immunity. How these immunity proteins recognize active 
lantibiotics and how they interact to protect the producers are not well understood (37). 
For class IIa bacteriocins, a single immunity protein is responsible for self-immunity. 
Immunity proteins showed high specificity for their cognitive bacteriocins although a 
few highly similar proteins provide cross-immunity to multiple bacteriocins (45). It 
was observed that the specificity of certain immunity proteins depends on which host 
strain they are expressed, suggesting that strain-specific factors could be involved in 
immunity. It may explain why some bacteriocin-negative bacteria are naturally 
insensitive to bacteriocins. This hypothesis was supported by the finding that an 
immunity protein OrfY which had no known cognitive bacteriocin broadened the 
immunity to multiple bacteriocins (13, 45). More research is needed to address this 
poorly understood but fundamentally important area. Little is known about the 
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molecular action of the immunity protein. It was found that immunity proteins may 
not interact extensively with the membrane due to their electrostatic polarity of the 
surface patches and due to the consistency of their three-dimensional structures in both 
aqueous and membrane-mimicking environments (63). It implied that the cognitive 
bacteriocin and the immunity protein would be located on the opposite sides of the 
cytoplasmic membrane, which raised a question of whether any more potential factors 
in the membrane could be involved in the action of immunity. A recent study shed 
light on the mysteries of why target bacterial strains are deferentially immune to 
bacteriocins and how immunity proteins act to protect producers. Diep and co-workers 
showed evidence for the existence of a membrane receptor for lactococcin A and class 
IIa bacteriocins (35). The mannose phosphotransferase system (man-PTS) appeared to 
be a receptor for the antimicrobial action of bacteriocin. Heterologous expression of 
the man-PTS operon rendered insensitive strains susceptible to lactococcin A and class 
IIa bacteriocins such as enterocin P, pediocin PA-1, sakacin A and penocin A. The 
man-PTS system consists of subunits IIAB, IIC and IID. Experimental evidence 
showed that IIC and IID are the targets for these bacteriocins. In the bacteriocin 
producer cell, the immunity protein, instead of directly sequestering bacteriocins in the 
membrane as many researchers had hypothesized, can form a complex with IIC and 
IID so that an “on-off” type transformation can function to render the producer cell 
immune to its own bacteriocin. Therefore, man-PTS may serve a universal receptor for 
many bacteriocins and immunity proteins complex with it to protect the producer cells. 
Although development of resistance to bacteriocins in naturally sensitive strains is a 
rare phenotype compared to bacterial resistance to antibiotics, spontaneous resistance 
of L. monocytogenes to bacteriocins was observed (32, 52, 81). Frequency of 
spontaneous resistance to nisin and pediocin is in the range of 10
-2
-10
-7
 depending on 
the strain and food system. Cross-resistance to multiple bacteriocins was also observed 
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(81). Stability of resistance varied with different bacteriocins and strains. However, 
nisin and class IIa bacteriocin resistance comes along with varying degrees of growth 
inhibition. It was found that the expression of the man-PTS operon was down-
regulated or missing in highly resistant mutants of L. monocytogenes (53). Alterations 
in membrane composition of L. monocytogenes may also contribute to resistance (31). 
Questions about how widely bacteriocin resistance can develop in different foods and 
different species, and how stable resistance can remain are not well answered. No 
evidence has been established to support cross-resistance between bacteriocins and 
antibiotics. 
Mode of action and antimicrobial spectrum. Nisin can adsorb to target cell by 
binding to lipid II as a docking molecule and then insert itself into the cytoplasmic 
membrane to form pores that lead to leakage of solutes of the target cell and cell death 
(12). By docking lipid II, which is a precursor for peptidoglycan, nisin also inhibits 
biosynthesis of the cell wall. Several other lantibiotics were shown to act in a similar 
manner (27). The finding of lipid II as a receptor for nisin suggests that the diverse 
sensitivity among different bacteria is due to the differential concentration of lipid II in 
target cell walls. As discussed before, class IIa bacteriocins and class IId bacteriocins 
which is represented by lactococcin A, use the man-PTS subunits as a receptor to 
adsorb to target cells (35) and then form membrane pores. However, more research is 
needed to address the question whether or not the man-PTS serve as a universal 
docking molecule for all of class II bacteriocins. It is not known if class IIb and class 
IIc bacteriocins use the same mechanism although they all permeabilize the 
membranes of target cells. 
In general, class I bacteriocins such as nisin have a wider antimicrobial spectrum 
than class II bacteriocins. However, the antimicrobial activity of class IIa against L. 
monocytogenes is higher than nisin (64). Nisin is active against L. monocytogenes, 
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Bacillus cereus, Clostridium botulinum, Staphylococcus aureus and many lactic acid 
bacteria. Gram-negative bacteria are not sensitive to nisin; but nisin can be bactericidal 
to Gram-negative bacteria when used in combination with chelating agents such as 
EDTA to disrupt the outer membrane of Gram-negative cells (110). The broader 
activity spectrum of nisin is an advantage for inhibiting many pathogenic and spoilage 
bacteria in foods. However, the narrower spectrum of class IIa bacteriocins is not 
necessarily a disadvantage for application in foods. There is no doubt that the genus 
Listeria is the most sensitive to class IIa bacteriocins. Besides Listeria spp., the 
sensitivity of other genera is not prominent. Class IIa bacteriocins do not have 
antimicrobial activity against many lactic acid bacteria, which could be advantageous 
for application in fermentations where multiple cultures are used. In fermentations, the 
bacteriocinogenic culture may be co-inoculated with other starter cultures that are 
naturally insensitive to the bacteriocin and the bacteriocin produced in situ can inhibit 
other unwanted microflora, especially L. monocytogenes, which is a main safety threat 
to cheese and meat products. Two-peptide (class IIb) and cyclic (class IIc) bacteriocins 
have broad spectrums. Enterocin AS-48, a well studied cyclic bacteriocin, can inhibit 
Gram-positive and even Gram-negative bacteria including Salmonella spp. and E. coli 
(1, 51). The spectrum of class IId bacteriocins is very narrow. 
Biological control of human pathogens using bacteriocinogenic lactic acid bacteria 
as bioprotective cultures may be an alternative strategy to improve sprout safety due to 
their sustainable antimicrobial properties produced during the whole process of 
sprouting regardless of seed structures where pathogens could be trapped inside. 
The objectives of this study were to isolate naturally occurring LAB from sprouts, 
characterize potentially new bacteriocins produced by isolates, and to investigate the 
potential of mild heating and bioprotective LAB cultures as multiple hurdles to 
decontaminate seeds and control the growth of pathogens on sprouts. 
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CHAPTER 2 
THERMAL INACTIVATION OF Salmonella spp. AND Escherichia coli O157:H7 
ON ALFALFA SEEDS
1
 
 
ABSTRACT 
Alfalfa seeds inoculated with five strains of Salmonella spp. or E. coli O157:H7 
were subjected to dry heat at 55ºC for up to 8 days. Five-log reductions in 
Salmonella spp. or E. coli O157:H7 on seeds were observed. No pathogens were 
detected on the sprouted seeds which were initially inoculated with ca. 2 log 
CFU/g of Salmonella spp. or more than 8 log CFU/g of E. coli O157:H7. The 
germination percentages of the alfalfa seeds did not significantly decrease after 6 
days of heating at 55ºC. These results showed that heat treatment of alfalfa seeds 
at 55ºC for up to 6 days was effective in enhancing the safety of alfalfa sprouts 
without affecting germination significantly.  
INTRODUCTION 
  Since the first large international outbreak of salmonellosis in the United States and 
Finland in 1995, the safety of eating fresh raw sprouts, especially alfalfa sprouts has 
been a major concern for consumers
 
(21). The pathogens found on seeds are thought to 
originate from environmental sources during seed production at the crop level.  The 
contamination levels of seeds are usually low in numbers (21). However, during 
sprouting, temperatures of approximately 30ºC and high humidity create favorable 
conditions for the rapid growth of pathogens that initially may be at below detectable 
                                                 
1 This chapter has been published in the Journal of Food Protection, 2007, 70: 1698-1703, by 
Guoping Feng, John J. Churey and Randy W. Worobo, Department of Food Science and 
Technology, Cornell University, Geneva, NY 14456. Reprinted with permission from the Journal 
of Food Protection. Copyright held by the International Association for Food Protection, Des 
Moines, Iowa, U.S.A. 
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levels on seeds but increase to more than 10
7
 CFU/g within 24 hours of sprouting, 
which pose a health risk to consumers. 
A number of physical and chemical methods have been evaluated for their 
effectiveness in inhibiting or eliminating bacterial foodborne pathogens on seeds and 
sprouts. Soaking alfalfa seeds inoculated with 2.4-3.23 log CFU/g of E. coli O157:H7 
in 20,000 ppm active chlorine, in combination with heating at 55 ºC was found to be 
effective in reducing pathogen levels to below detectable levels. However, pathogens 
were still detected by enrichment (20). In response to this finding, the U.S. Food and 
Drug Administration (FDA) recommended that soaking alfalfa seeds in 20,000 ppm 
calcium hypochlorite for 15 min, be used as a seed decontamination treatment prior to 
sprouting. However, in 1999 still another multi-state outbreak of salmonellosis due to 
alfalfa sprouts occurred despite the sprout manufacturer following FDA recommended 
chlorine treatment prior to sprouting. This suggested that the hypochlorite treatment of 
the seeds insufficiently reduced the levels of contaminating pathogens associated with 
the seeds used for sprouting (17). Although it was reported that 20,000 ppm free 
chlorine soak for 10 min was still effective in eliminating Salmonella Mbandaka from 
naturally contaminated seeds (19), other studies showed that the efficacy of 20,000 
ppm chlorine was questionable in eliminating Salmonella spp., which grew to more 
than 7 log CFU/g on sprouts even with spray application of 100 ppm chlorine during 
germination (10). Re-growth of E. coli O157:H7 to 7 log CFU/g on sprouts after 
20,000 ppm hypochlorite treatment for 15 min has also been observed (14). Many 
other studies have examined the effectiveness of various chemicals including chlorine 
at various concentrations (3-5, 11, 13, 15, 16, 18, 24, 25), indicating that none of the 
sanitizers were able to eradicate Salmonella or E. coli O157:H7 without affecting 
germination, although significant reduction of the pathogens was observed. Physical 
treatments, including Gamma irradiation (22) and heating in hot water (23) as a means 
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to decontaminate Salmonella and E. coli were confirmed to be capable of reducing the 
population on seeds and sprouts significantly, but complete elimination was not 
observed. High hydrostatic pressure can reduce E. coli O157:H7 populations by 2 logs 
but results in extremely poor germination of the seeds (1). Biocontrol of Salmonella 
spp. by plant-associated pseudomonads was studied and found to be effective in 
inhibiting the growth of Salmonella but was unable to reduce the populations on 
sprouts (9). 
It is the physiology of alfalfa seeds that complicates the disinfection of pathogenic 
bacteria. Researchers have postulated that removing pathogens from alfalfa seeds is 
more difficult than from other seeds because alfalfa seeds have wrinkles (7) and 
crevices on the surface, allowing pathogens inside these protective structures and 
making them inaccessible to chemical sanitizers. The biofilms formed by pathogens 
on sprouts may provide protection against antimicrobial compounds used for 
decontamination (8).  
Heat treatment, by soaking seeds in hot water, has been tried by many researchers, 
resulting in limited reduction of the pathogens and usually decreases in seed 
germination rates (18, 19, 23). Dry heat has been shown to be an effective 
decontamination treatment for mung bean without affecting the seed viability (12). 
However, dry heat has not been extensively studied for alfalfa seeds. Dry heat could 
be a promising treatment, because heat transfer will not be hindered by seed 
physiological structures, such as crevices or wrinkles that provide protection to 
pathogens when chemical treatments are applied to alfalfa seeds.  
The purpose of this study was to investigate the effects of dry heat on the viability 
of E. coli O157:H7 and Salmonella, the two most frequent pathogens that have been 
responsible for the widespread outbreaks associated with alfalfa sprout consumption, 
and the effect on the viability of alfalfa seeds with various heat treatments.  
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MATERIALS AND METHODS 
Cultures and Media. Five serovars of Salmonella enterica and five different 
strains of E. coli O157:H7, were used as inocula: Salmonella Gaminara, Salmonella 
Hartford, Salmonella Typhimurium, Salmonella Rubislaw and Salmonella 
Montevideo; E. coli O157:H7 ATCC 43889 (clinical isolate), ATCC 43894 (clinical 
isolate), ATCC 43895 (raw hamburger meat isolate), 933 (raw hamburger meat 
isolate), provided by M. P. Doyle, Center for Food Safety, University of Georgia, and 
ATCC 35150 (clinical isolate) provided by J. Russell, Department of Microbiology, 
Cornell University. To facilitate the enumeration of colonies on tryptic soy agar (TSA), 
all of the strains were transformed by electroporation with the plasmid encoding for 
green fluorescence protein (pGFP) and ampicillin antibiotic resistance. 
Inoculation and treatment.  For high inoculation levels on alfalfa seeds, each 
serovar of S. enterica or each strain of E. coli O157:H7 was loop-inoculated into 50 ml 
tryptic soy broth (TSB; Criterion, Hardy Diagnostics, CA, USA) containing ampicillin 
at 100 mg/L (Fisher Scientific, NJ, USA). Each 50 ml TSB with inoculum was 
incubated at 37 ºC with 250-rpm shaking for 18 h (Innova 4230, New Brunswick 
Scientific, Edison, NJ, USA). After incubation, five 50-ml strains of E. coli O157:H7 
or five serovars of S. enterica were mixed to make a cocktail of 250 ml inoculum. The 
cocktail was combined with 200 ml sterile deionized distilled water (Milli-Q RG, 
Millipore, Bedford, MA, USA) and 60 g of alfalfa seeds of the Lucerne variety 
(Springwater Sprouts Inc., Honeoye Falls, NY). Seeds were soaked in a 500 ml sterile 
beaker for 20 min at 20ºC with occasional agitation. 
For low inoculation levels, each serovar of S. enterica or each strain of E. coli 
O157:H7 was loop-inoculated into 5 ml of TSB containing ampicillin (100 mg/L). The 
cultures were incubated as described above. After incubation, every culture of E. coli 
O157:H7 was serially diluted in TSB 1,000-fold and Salmonella by 10,000-fold. One 
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milliliter of each diluted strain was combined to create a mix of all five strains or 
serovars for making a 5-ml cocktail of S. enterica or E. coli O157:H7. Sixty grams of 
seeds were soaked in 1 liter of sterile deionized distilled water inoculated with 5 ml of 
S. enterica or E. coli O157:H7 cocktails for 20 min at 20ºC with occasional agitation. 
After soaking, the seeds were poured onto two layers of sterile cheesecloth, which 
was laid on a raised stainless steel mesh (10 by 25 cm; Hoeltge Inc., Cincinnati, OH). 
Seeds were evenly spread to form a uniform thickness of approximately 5 mm and 
allowed to dry overnight in a biological safety cabinet (Nuaire Inc., Plymouth, MN).  
Eight grams of dried inoculated seeds were placed into 15-ml sterile plastic 
centrifuge tubes (Fisherbrand, Fisher) and heated at 55 ºC for 4, 6 and 8 days in the 
same incubator described above. The capped tubes were placed horizontally on a rack 
to allow the seeds to spread evenly over the tube interior, ensuring equal heating.  
Germination. After 0, 4, 6 and 8 days of incubation at 55 ºC, 1 g of seeds (ca. 550 
seeds) were placed into 50 ml sterile centrifuge tubes (Simport Plastics, Beloeil, 
Quebec, Canada). The tubes were filled with sterile distilled water to 50 ml. Seeds 
were soaked for 4 h with occasional agitation. The seeds were poured onto a 3M filter 
paper (Fisher) in a sterile plastic container (12 by 8 by 6 cm) that was used to simulate 
the normal sprouting conditions. The filter paper was placed on top of a sponge inside 
the plastic container to provide humidity during germination. The seeds were evenly 
spread over the filter paper with a sterile glass rod to ensure every seed was in contact 
with the filter paper.  
The seeds were incubated at 30 ºC for 3 days before the germination rate of the 
seeds and pathogen population levels of the sprouts were determined. During the time 
of germination, sterile distilled water was sprayed on the seeds/sprouts twice daily (12 
h apart) to maintain the amount of moisture the seeds require for sprouting. The 
germination percentage was calculated by dividing the number of germinated seeds by 
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the total number of seeds in the sample at the time of germination.  The treatments and 
germinations were performed in triplicate in separate containers. Ruptured seeds with 
cotyledons still intact inside the cuticle were not considered germinated but 
enumerated as part of the total seed numbers.  
Bacterial Analysis. After inoculation, drying or heating, 1 gram of the alfalfa seeds 
was sampled and mixed with 9 ml of 0.1 % peptone water in a 60-ml sterile stomacher 
bag (Fisherbrand, Fisher). The bag was stomached at 260 rpm for 60 s (Stomacher 
400, Seward Ltd., Basingstoke, UK).  The homogenate was serially diluted in sterile 
0.1% peptone water. For the seeds inoculated with Salmonella, duplicate 0.1-ml of 
each dilution and quadruplicate 0.25-ml portions of the undiluted mixture were surface 
plated onto TSA (Difco, Becton, Dickinson, Sparks, MD) supplemented with 
ampicillin (100 mg/L) and onto Hektoen enteric Agar (HEA; Criterion, Hardy); for the 
seeds inoculated with E. coli O157:H7, the dilutions were surface plated by the same 
method as described above except for the use of violet red bile agar with MUG (4-
methylumbellifery-β-glucuronide) (VRBA; Difco, Becton, Dickinson) in lieu of HEA.  
When the seeds had been sprouted for 3 days, 3-6 g of the sprouts were combined 
10-fold with 0.1 % peptone water. Three separate containers were sampled and 
assayed for surviving populations of Salmonella and E. coli O157:H7 on sprouts by 
the same method mentioned above.  
TSA plus ampicillin medium and VRBA were incubated at 37 ºC for 24 h, and 
HEA was incubated for 48 h. The enumeration of the colonies on TSA plus ampicillin 
medium was done under UV light of 320 nm. Only the colonies that exhibited green 
fluorescence were counted on TSA plus ampicillin. Typical colonies on HEA and 
VRBA were also counted. Suspected colonies that appeared to be E. coli O157:H7 or 
Salmonella spp. were confirmed using Chromagar O157 and Chromagar Salmonella 
(BBL, Becton Dickinson, Sparks, MD). 
  49 
All the experiments were performed in separate triplicate trials with duplicate 
plating. 
Statistical Methods. The percentages of germination from a series of treatment 
times were compared with the control (no heating time) to determine if heat treatments 
reduce the germination significantly by the Dunnett method.  Analysis of variance 
between treatments with different heating times was used to compare mean values of 
pathogen population on sprouts. All of the statistical analyses were conducted by the 
software JMP 5.1.2 (SAS Institute Inc., Cary, NJ). 
RESULTS 
Remaining Salmonella populations. As Table 2.1 indicates, the levels of 
Salmonella on seeds decreased compared with the untreated control seeds. However, 
Salmonella on sprouts from all treatments and control seeds rapidly increased to 
approximately the same levels during sprouting, regardless of the treatment and 
Salmonella reduction achieved on the seeds. The increase in Salmonella levels on the 
sprouts is even much higher considering the increase in weight and surface area that 
occurs during the sprouting process. 
It is noticeable that overnight drying of freshly inoculated seeds resulted in 
approximately 1-log reduction of Salmonella. Similar results were also found in the 
subsequent experiments of this study. With the high inoculation level of 8.00 log 
CFU/g, Salmonella was inactivated by more than 5 logs on seeds after 6 days of 
heating at 55ºC (Table 2.1). After 8 days of heating, the population of Salmonella on 
seeds was below detection limits (1 log CFU/g or 10 CFU/g of seeds). After 3 days of 
sprouting with favorable conditions for pathogen growth (incubation at 30 ºC and 
water spraying), the populations of the pathogens from different batches of sprouts 
treated for 4 d, 6 d and 8 d were not significantly different from each other (P>0.05, 
not marked in Table 2.1), suggesting that the final pathogen populations on the sprouts 
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were not related to the different treatment times as long as there was Salmonella 
surviving on or inside the seeds. On TSA plus ampicillin, pathogen populations on the 
seeds were below the detection limit after 8 d of heating, while it was already 
undetectable on HEA, even after 6 d of heating. However, after 3 d of sprouting, the 
pathogens grew quickly to high numbers on sprouts even though it was below 
detectable limit on the seeds. Although the numbers of Salmonella on sprouts were 
lower than that of the control, it is obvious that with high inoculation levels, heating at 
55ºC had little effect on the reduction of the pathogen on sprouts, while it was easy to 
obtain a 5-log reduction on seeds. The likely reason for this observation is that there 
were surviving pathogens on seeds, although they were too few to be detected, and 
they could grow to high numbers on sprouts during the sprouting process, which 
allows rapid pathogen growth. It was found that, normally, there was a difference in 
pathogen counts between TSA plus ampicillin and HEA, especially for sprouts. The 
difference could be attributed to the lack of recovery for heat-injured cells and a 
proportion of the total cells that lost the pGFP plasmid and, as a consequence, were no 
longer ampicillin resistant or capable of producing green fluorescent protein. 
However, plasmidless cells grew on the selective medium HEA, resulting in an 
enumeration difference. 
After the seed inoculation level was lowered to ∼2 log CFU/g, the pathogen was 
still capable of growing to high numbers on sprouts after the sprouting process from 
untreated seeds (control) (Table 2.1), although on TSA plus ampicillin, it was below 
detection limits prior to sprouting. As the results of both TSA plus ampicillin and 
HEA show, the pathogens on all heat treated seeds for 4 d, 6 d and 8 d were not 
detected. Furthermore, no pathogens were detected on sprouts after 3 d of sprouting at 
30ºC, indicating that heating process is effective in eradicating the pathogens from the 
seeds. 
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Table 2.1. Thermal inactivation (at 55ºC for up to 8 days) of Salmonella on alfalfa 
seeds at high and low inoculum levels of 8.00 (8.69) log CFU/g and 2.17(2.63) log 
CFU/g, respectively. 
 
Salmonella (Log CFU/g seeds or 
sprouts) on seeds and sprouts 
with high inoculum level 
Salmonella (Log CFU/g seeds or 
sprouts) on seeds and sprouts 
with low inoculum level 
Heating time 
(days) 
After heating 
After 3d of 
sprouting 
After heating 
After 3d of 
sprouting 
0 
NA
 
(NA) 
6.64±0.14 
(ND) 
NA 
(NA) 
4.35±1.50 
(7.04±0.09) 
4 
2.14±0.14 
(1.49±0.20) 
5.92±0.14 
(8.50±0.12) 
<1 
(<1) 
<1 
(<1) 
6 
1.32±0.28 
(<1) 
5.82±0.91 
(8.61±0.36) 
<1 
(<1) 
<1 
(<1) 
8 
<1 
(<1) 
5.73±0.45 
(8.91±0.09) 
<1 
(<1) 
<1 
(<1) 
 
Note: After drying, the levels of Salmonella on seeds were 6.79 (7.19) log CFU/g and <1(1) log 
CFU/g for high and low inoculum levels, respectively. Data were from TSA plus ampicillin and 
from HEA (in parentheses). Values are means of triplicates except those under detection limit. NA, 
not applicable. ND, not determined. 
 
 
Remaining E. coli O157:H7 populations. E. coli O157:H7 remained on the sprouts 
at almost the same level of cell concentrations on the seeds that did not undergo heat 
treatment (Table 2.2). For the seeds with high inoculation levels, the pathogens on the 
seeds were detected at low numbers on TSA plus ampicillin while on VRBA no cells 
were detected on the seeds after 4 d of heating at 55ºC. The reduction of more than 5 
log on seeds was achieved by heating the seeds at 55ºC for 4 days or more.  However, 
during sprouting, E. coli O157:H7 quickly grew to high levels even if it was below the 
detection limits on VRBA from the seeds that underwent 4 days of heating. After 6 
days of treatment, the pathogens were below detectable limits on the seeds.  
 
  52 
Table 2.2. Thermal inactivation (at 55ºC for up to 8 days) of E. coli O157:H7 on 
alfalfa seeds at high and low inoculum levels of 8.75 (8.68) log CFU/g and 3.15(3.00) 
log CFU/g, respectively. 
 
E. coli O157:H7 (Log CFU/g 
seeds or sprouts) on seeds and 
sprouts with high inoculum 
level 
E. coli O157:H7 (Log CFU/g 
seeds or sprouts) on seeds and 
sprouts with low inoculum level 
Heating time 
(days) 
After heating 
After 3d of 
sprouting 
After heating 
After 3d of 
sprouting 
0 
NA
 
(NA) 
8.59±0.08 
(8.59±0.10) 
NA
 
(NA) 
7.43±0.22 
(7.44±0.13) 
4 
1.6 
(<1) 
6.96±0.27 
(6.88±0.23) 
<1 
(<1) 
5.73 
(6.17±0.44) 
6 
<1 
(<1) 
<1 
(<1) 
<1 
(<1) 
<1 
(<1) 
8 
<1 
(<1) 
<1 
(<1) 
<1 
(<1) 
<1 
(<1) 
 
Note: After drying, the levels of E. coli O157:H7 on seeds were 7.29(6.82) log CFU/g and 2.33 
(2.02) log CFU/g for high and low inoculum levels, respectively. Data were from TSA plus 
ampicillin and from VRBA (in parentheses). Values are means of triplicates except those under 
detection limit. NA, not applicable. 
 
 
Table 2.3. The germination percentages of alfalfa seeds heated at 55ºC for up to 8 days 
with (A) and without inoculation procedures (B). 
 
Germination Percentages (%) Heating time 
at 55ºC Treatment A Treatment B 
Positive 
Control (0d) 
 
82.0±3.5 a 82.8±0.7 a 
4d 62.0±6.5 b 78.7±4.0 a 
6d 59.7±4.2 b 76.8±2.9 a 
8d 47.0±3.7 b 74.6±2.0 b 
 
Note: All data are mean values of separate triplicates. Values in the same column followed by a 
letter that is different from that of the control are significantly different from the control (P<0.05). 
Treatment A was inoculation of the alfalfa seeds with high level of Salmonella, followed by drying 
the seeds in a laminar flow hood and then heating the seeds at 55 ºC for up to 8 days; Treatment B 
was heating the seeds in the same method but without an inoculation procedure, imitating the 
industrial procedure. 
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After sprouting, E. coli O157:H7 was still below detectable limits on the sprouts. 
Therefore, the temperature and time regime of this heat treatment was effective in 
killing high levels of E. coli O157:H7 on sprouts. 
The effect of heat treatment on low levels of inoculation was also investigated. 
Seeds were inoculated with E. coli O157:H7 cocktail at the level of ∼3 log CFU/g 
(Table 2.2). A ca. 1-log reduction was also observed after the seeds were dried in the 
flow hood. The pathogens on untreated seeds grew to more than 7 log CFU/g on 
sprouts after the sprouting process. Heating the seeds at 55ºC for 4 days was effective 
in reducing pathogen levels to below detectable limits. However, large numbers of E. 
coli O157:H7 were still observed after sprouting. For 6 days or more of heating, no 
pathogens were observed on both TSA plus ampicillin and VRBA media. Furthermore, 
pathogens were under detection limits on sprouts, suggesting that the treatment of 
55°C for 6 days had eradicated the pathogens from the seeds. 
Germination percentages of treated seeds. After inoculation with high levels of 
Salmonella, drying in the laminar flow biological safety cabinet, heating at 55 ºC for 
up to 8 days and sprouting the seeds for 3 days, the germination percentages were 
obtained by counting the sprouts from the different treatments. It was found that the 
germination of the seeds decreased significantly (P<0.05) from 82.0% to 62.0%, 
59.7% and 47.0% for 4, 6 and 8 days of heating at 55°C, respectively, when compared 
with the control (Table 2.3). 
The germination of the seeds that underwent heat treatment without inoculation 
procedures was investigated to determine the extra effects, if any, of the inoculation on 
seed viability. The percentage of germination of the heat treated seeds still remained at 
78.7% and 76.8% with 4 and 6 days of heating, respectively. The percentages of 
germination of the seeds that were heated for 4 and 6 days were not significantly 
different from the control, 82.8% (P>0.05). After 8 days of heating, the germination 
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decreased to 74.60%, which was significantly different (P<0.05) from the control. The 
overall appearance of the treated sprouts was not different from the control. 
DISCUSSION 
From the results obtained in this study, it was possible to achieve a 5-log reduction 
of both Salmonella and E. coli O157:H7 on alfalfa seeds without significantly 
affecting the seed viability. However, after the sprouting process, both Salmonella and 
E. coli O157:H7 were shown to grow to dangerously high levels of 5 to 7 log CFU/g 
or more than 7 log CFU/g, even though they were not detected on the seeds after the 
heat treatment (Tables 2.1 and 2.2). This suggests that pathogen enumeration of the 
sprouts is crucial, even after seed decontamination treatments. 
Seeds inoculated at high levels of E. coli O157:H7 and heat treated at 55°C for ≥4 
days resulted in alfalfa sprouts that were below detectable levels. However, only seeds 
inoculated with low inoculum levels of Salmonella and heat treated at 55°C for ≥4 
days resulted in sprouts that were below detectable levels. These results suggest that 
the higher heat resistance of the Salmonella strains allowed for lower inactivation rates 
in seeds and consequently the presence of Salmonella in sprouts. 
It has been reported that Salmonella grows faster (6) and attaches more tightly to 
the surfaces of the alfalfa sprouts (2) than does E. coli O157:H7 during the sprouting 
process. In this case, Salmonella might recover more quickly from heat stress than E. 
coli O157:H7. Therefore, Salmonella is more recalcitrant for the elimination from 
alfalfa seeds. 
    It was observed that with alfalfa sprouts, there was a large gap in the numbers of 
typical colonies of Salmonella formed on TSA plus ampicillin and HEA media, while 
the numbers of E. coli O157:H7 on TSA plus ampicillin were in close agreement with 
those on VRBA. This observed difference might be attributable to the instability of the 
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plasmid (pGFP) in Salmonella cells. Current studies are being performed to confirm 
this hypothesis. 
In this study, heating alfalfa seeds at 55ºC for 4 or more days was capable of 
achieving a >5 log reduction in both Salmonella and E. coli O157:H7 populations, 
which greatly enhanced the safety of alfalfa sprouts. This method is effective only in 
removing low levels of Salmonella contamination on seeds, while it is effective in 
eradicating high contamination levels of E. coli O157:H7 at more than 8-log CFU/g 
contamination levels. Under normal conditions, the pathogens contaminate the seeds 
at very low numbers before harvest. The effectiveness of this method to decontaminate 
pathogens at artificially high pathogen levels should be sufficient for naturally 
contaminated seeds at much lower pathogen contamination levels. Higher 
temperatures were attempted and showed faster kill rates, but the germination rates 
were significantly reduced. The germination of alfalfa seeds was greatly reduced at 
temperatures higher than 55 ºC after several days of holding (data not shown). 
The difference in the percentages of germination of heated seeds with and without 
inoculation could be attributed to the inoculation effect on the viability of the seeds. 
To be inoculated, the seeds were soaked in the inoculum for 20 min and then dried 
overnight in the laminar flow biological safety cabinet. These procedures could add to 
the effects of heat in reducing the germination rate of the alfalfa seeds. The combined 
effects of inoculation and heating resulted in the significant reduction of seed viability. 
The results from the heated seeds without inoculation indicated that heat treatment at 
55ºC for up to 6 days did not reduce the percentage of germination significantly, and 
even after 8 days of heating, the germination was still acceptable. The percentages of 
germination obtained in this study showed that dry heat at 55ºC could be an effective 
treatment for ensuring the safety of the alfalfa sprouts without affecting the viability of 
the alfalfa seeds significantly.  
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Dry heat is more practical and promising, because the germination of alfalfa seeds 
appeared to be less sensitive to dry heat than to heat in hot water. Hot-water treatment 
for alfalfa seeds at around 55ºC or more than 55ºC was previously reported to be 
detrimental to seed viability, even for several minutes of treatment (13, 18, 23). 
However, this study indicates that the germination of alfalfa seeds was stable for 
several days of dry heat at 55ºC, suggesting that dry heat may be applicable to the 
sprout industry both in terms of safety assurance and of maintaining an acceptable 
percentage of germination for the producers. 
It is the wrinkled surface seed structure of alfalfa seeds that makes the eradication 
of pathogens from seeds difficult. Some pathogens remain inside the seed coat, 
wrinkled grooves or crevices that are not accessible to chemical sanitizers; hence, 
there is incomplete access to the contaminating pathogens by chemical sanitizers that 
largely work as surface sanitizers. However, heat transfer can penetrate the food 
matrix, regardless of the intricate structure of the seeds. Therefore, heat treatment can 
be an effective treatment for removing even internalized or protected pathogens from 
alfalfa seeds.  
The results of this study showed that heat treatment of seeds at 55ºC for up to 6 
days can be an effective method for ensuring the safety of the alfalfa sprouts without 
reducing the germination of the seeds significantly. Heat treatment may be a 
promising alternative to current ineffective methods because the treatment can easily 
be applied to large quantities of seeds prior to selling to sprout producers.  In addition, 
the application is easily monitored and recordable to ensure the proper treatment was 
applied. 
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CHAPTER 3 
CHARACTERIZATION OF MUNDTICIN L, A CLASS IIA ANTI-Listeria 
BACTERIOCIN FROM Enterococcus mundtii CUGF08
2
 
 
ABSTRACT 
Enterococcus mundtii CUGF08, a lactic acid bacterium isolated from alfalfa 
sprouts, was found to produce a bacteriocin. The bacteriocin, designated 
mundticin L, has high inhibitory activity specifically against the genus Listeria, 
including the foodborne pathogen Listeria monocytogenes and several other 
genera. Hybridization studies revealed that the gene cluster for mundticin L is 
contained on a large plasmid. The genetic determinants required for the 
bacteriocin production, including the structural gene for mundticin L, the genes 
for the ATP binding cassette (ABC) transporter and the immunity protein were 
cloned and sequenced. The precursor of mundticin L is comprised of 58 amino 
acids and a double glycine processing site at the C-terminus of the leader peptide. 
Mundticin L consists of 43 amino acids with an intramolecular disulfide bond 
following a YGNGX motif in the N-terminus, which is typical of class IIa 
bacteriocins. Compared to the homologous mundticin KS or ATO6 and enterocin 
CRL35, mundticin L has a unique leucine residue instead of the most commonly 
found valine as the fifth residue in the YGNGX motif. The amino acid sequence 
of the leader peptide is identical to that of CRL35 but different at residue 
positions −6 (Ala) and −10 (Ser) from that of mundticin KS. The sequences of the 
ABC transporter and immunity protein contains 674 and 98 amino acids, 
                                                 
2 The main part of this chapter has been published in Applied and Environmental Microbiology, 
2009, 75:5708-5713, doi: 10.1128/AEM.00752-09, by Guoping Feng, Giselle K. P. Guron, John J. 
Churey and Randy W. Worobo, Department of Food Science and Technology, Cornell University, 
Geneva, NY 14456. Reproduced and amended with permission from American Society for 
Microbiology. 
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respectively, and differ from those reported for KS and CRL35. The gene for 
mundticin L precursor is located in a single operon while the ABC transporter 
and the immunity protein are clustered in a separate downstream operon. 
INTRODUCTION 
Bacteriocins are ribosomally synthesized proteinaceous compounds that inhibit 
closely related bacteria (22). Due to consumer concerns with chemical and irradiation 
preservation methods, and the rising demand for minimally processed food products, 
alternative methods for shelf life extension and enhanced safety are needed. 
Bacteriocins are considered as “natural” antimicrobials since many bacteriocins are 
produced by food-grade lactic acid bacteria, which are generally recognized as safe 
(GRAS). 
Bacteriocins can be divided into three main classes: the class I lanthionine-
containing lantibiotics, exemplified by nisin; the class II non-lanthionine-containing 
bacteriocins; and the class III of heat-labile, large proteins (7). Class III bacteriocins 
have limited application due to their thermal instability and cytolytic activity against 
eukaryotic cells. Class II can be further divided into class IIa containing pediocin-like 
bacteriocins, class IIb containing two-peptide bacteriocins, and class IIc of other 
bacteriocins (10). Class IIa bacteriocins have been extensively studied since pediocin 
PA-1 was first discovered (15) and characterized (24). Currently, only nisin in class I 
has been approved by the FDA as a natural food additive. Bacteriocins belonging to 
class IIa are promising alternative antimicrobials since they are stable over a broader 
range of heating regiments and pH conditions. In addition, these bacteriocins exhibit 
stronger antimicrobial activity against the genus Listeria than nisin (20) but have a 
narrower antimicrobial spectrum. 
The potential applications of class IIa bacteriocins in both meat and plant-based 
foods as a means to provide protection against potential foodborne pathogens and 
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extend shelf life continue to expand. In an attempt to use biological methods for 
controlling foodborne pathogens on fresh sprouts, a number of food grade lactic acid 
bacteria were isolated from the indigenous microbiota on alfalfa sprouts. Some of 
these isolates were found to be bacteriocinogenic. This study describes a new class IIa 
bacteriocin, mundticin L produced by Enterococcus mundtii CUGF08 isolated from 
alfalfa sprouts. 
MATERIALS AND METHODS 
Media and Cultures. The mundticin L producer E. mundtii CUGF08 was obtained 
from alfalfa sprouts. MRS broth (Difco, Becton Dickinson and Company, Sparks, MD 
and Criterion, Santa Maria, CA) was used to grow lactic acid bacteria including the 
bacteriocin producers Enterococcus mundtii CUGF08 and Enterococcus mundtii 
ATO6 (3). The indicator strain Listeria ivanovii and other bacteria used for 
antimicrobial spectrum determination and activity titration were grown in tryptic soy 
broth (TSB; Difco; Table 3.1). Agar media contained 1.5% (wt/vol) agar (Difco) and 
soft agar used for overlay contained 0.75% agar. Escherichia coli DH5α with the 
cloning vector pUC19 were grown in LB media (Difco) containing 100 µg/mL of 
ampicillin (Fisher Scientific, Fair Lawn, NJ). E. coli ElectroMAX DH5α-E 
electrocompetent cells (Invitrogen, Carlsbad, CA) were used for transformation of 
recombinant pUC19. LB agar containing ampicillin (100 µg/mL), 120 µg/mL of 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) (Fisher Scientific) and 40 µg/mL of X-
gal (Fisher Scientific) was used to screen transformed cells. Stock cultures were 
maintained at −80°C in the respective media without antibiotics but supplemented 
with 15% glycerol (Fisher Scientific). 
Identification of the isolates. The genus and species of the isolates were 
determined by phenotypic and genetic characterization. The 16S rRNA gene was 
amplified in a 50 µL PCR reaction containing 50 pmol of each primer, 16S-F (5’–
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AGAGTTTGATCCTGGCTCAG –3’) and 16S-R (5’–
AAGGAGGTGATCCAGCCGCA–3’) (12), approximately 0.05 µg of chromosomal 
DNA, 0.2 mM of each deoxynucleoside triphosphates (Fisher Scientific), and 2.5 units 
of Taq polymerase (Fisher Scientific). PCR was carried out under the following 
conditions: one step of denaturing at 94°C for 3 min, 30 cycles of denaturing at 94°C 
for 1 min, annealing at 37°C for 2 min and extension at 72°C for 1.5 min, and one 
final step of extension at 72°C for 8 min in a RoboCycler (Stratagene, La Jolla, CA). 
The PCR product was purified by QIAquick gel extraction kit (Qiagen, Germantown, 
MD) and then sequenced on an Applied Biosystems Automated 3730 DNA Analyzer 
(Foster City, CA) at Cornell University Life Sciences Core Laboratories Center. The 
sequence was analyzed for homologous sequences using the BLAST program of 
National Center for Biotechnology Information (26) to determine the identity of the 
isolate. 
Characterization of bacteriocin. Bacteriocin production was confirmed by 
performing a deferred inhibition assay as described by Schillinger and Lücke (32), 
with the following modifications. A pure culture of each isolate was spotted onto MRS 
agar and incubated at 30°C for 24 h. Proteolytic enzymes were used to confirm the 
proteinaceous nature of bacteriocins. Ten-microliter aliquots of different proteolytic 
enzymes, including proteinase K (20mg/ml, Fisher Scientific), pronase E (10 mg/ml, 
Sigma, Saint Louis, MO) were added close to the 24-h colonies. After drying, 8 ml of 
soft agar (0.75%, wt/vol) medium containing 0.05 ml of an 18h culture of an indicator 
strain was overlaid. To eliminate the antimicrobial effect of acids produced by lactic 
acid bacteria, 10 µl of Tris buffer (2M Tris-HCl, pH 8.0) was added as described 
above for proteolytic enzymes. The plates were incubated for an additional 24 h. Clear 
inhibition zones, inactivated by any of the proteolytic enzymes but unaffected by the 
Tris buffer, were considered as an indication of bacteriocin production by the isolates. 
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The bacteriocin was extracted (as described below) and subjected to Tricine-sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (Tricine-SDS-PAGE) (30, 31) 
using a Mini-Protean II electrophoresis system (Bio-Rad, Hercules, CA). Duplicate 
gels were run at 120 V for 1.5 h before they were stained with Coomassie Blue G-250 
(Bio-Rad). Ultra-low-range molecular weight marker (molecular weights, 1,060 - 
26,600; Sigma) was used to estimate the molecular weight of the unknown 
bacteriocin. Following fixation with methanol (30%, wt/vol), one of the duplicate gels 
was overlaid with 8 ml of soft agar containing 50 µL of the late-log-phase sensitive 
indicator strain. 
Determination of antimicrobial activity and spectrum of activity. The activity of 
the bacteriocin was titrated by a spot diffusion assay (9). The cell-free supernatant 
containing maximum activity of the bacteriocin was prepared by centrifuging and 
filtering through a 0.2 µm pore-sized cellulose acetate membrane (VWR International, 
West Chester, PA). The filtrate was subjected to 2 fold serial dilutions in 50 mM 
sodium phosphate buffer (pH 7.0) and 10 µL of each dilution was spotted onto a lawn 
of the indicator strains. The lawns were prepared by overlaying 8 mL of TSB or MRS 
soft agar inoculated with 50 µL of Listeria spp. and other strains over a base agar 
medium (TSA or MRS; Table 3.1). Following drying in a laminar flow hood, the 
spotted plates were incubated for 24 hours at 30˚C for lactic acid bacteria and 37˚C for 
other strains. The antimicrobial activity of the bacteriocin was measured using Listeria 
ivanovii as the indicator strain. The antimicrobial activity was defined as the reciprocal 
of the highest dilution showing definite inhibition in the indicator lawn. The activity 
was expressed in arbitrary unit per ml (AU/ml). The antimicrobial spectrum of the 
bacteriocin and the minimum inhibitory concentration of the tested strains were 
determined using the same method. 
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Isolation, cloning and sequencing of the bacteriocin genetic determinants. 
Standard molecular biology methods described by Sambrook and Russell (29) were 
used, unless otherwise noted. E. mundtii CUGF08 chromosomal DNA was purified 
from a 30-ml overnight culture using a method described by Mengaud et al. (25), with 
modifications. The cloning vector pUC19 and subsequent recombinant plasmids from 
E. coli DH5α were purified using a plasmid mini kit (Qiagen) according to the 
procedures described by the manufacturer. Plasmids from lactic acid bacteria were 
isolated following the method described by Anderson and McKay (1). PCR products 
were purified with a QIAquick gel extraction kit. The DNA concentration was 
determined with a NanoDrop ND 1000 (Thermo Scientific, Waltham, MA). 
Restriction enzymes were obtained from Fisher Scientific or Promega, Madison, WI.  
To isolate the bacteriocin gene cluster, restriction enzyme (Fisher Scientific, and 
Promega, Madison, WI) digestions of genomic DNA were carried out in 50 µL 
reactions containing 1-2 µg of DNA for 1-2 h at 37°C. The digested DNA was 
subjected to electrophoresis at 2 V/cm for 4.5 h before staining with ethidium bromide 
(0.5 µg/mL). DNA in the gel was alkaline transferred onto a positively charged 
Hybond-N+ nylon membrane (Amersham, United Kingdom). The DNA was fixed to 
the membrane at 120 mJ/cm
2
 by a UV cross-linker and hybridized with the PCR 
product from the amplified relevant bacteriocin genes as probes. The probes were 
labeled with thermostable alkaline phosphatase and detected by GE Amersham 
AlkPhos Direct Labeling and CDP Star Detection Systems. Developer and fixer 
solutions and chemiluminescence film (Kodak, Rochester, NY) were used to visualize 
the hybridization patterns. 
The restriction fragments that hybridized with the PCR amplified bacteriocin genes 
were cloned into the multiple cloning sites of pUC19. Briefly, fragments were 
recovered from agarose gel after electrophoresis of digested genomic DNA as 
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described above. DNA in the recovered gel was electroeluted into a dialysis bag 
(MWCO 500 Da; Spectrum, Rancho Dominguez, CA) at 5 V/cm for 30 min. The 
electroeluted DNA was purified by chloroform/phenol extraction and standard ethanol 
precipitation. The cloning vector pUC19 was digested with compatible restriction 
enzymes that were used to digest the genomic DNA. The vector DNA digested by a 
single restriction enzyme was dephosphorylated using shrimp alkaline phosphatase 
(Boehringer Mannheim, Germany) prior to ligation. T4 ligase (Invitrogen) was used to 
ligate the recovered insert and vector at the molar ratio of 3:1 (9 fmol to 3 fmol) in a 
20 µL reaction. The reaction was diluted 5 fold prior to transformation. 
Transformation was carried out by electroporating 1 µL of the diluted ligation mixture 
with 20 µL of competent E. coli DH5α cells and electroporated at 2.0 kV, 200 Ω and 
25 µF (Gene Pulser II, Bio-Rad) in 2.0 mm-gapped electroporation cuvettes (Bio-
Rad). The transformed cells were plated to LB agar containing ampicillin, IPTG and 
X-gal. Colonies from the transformation were blotted and transferred onto nylon 
membranes (Amersham). The membrane was hybridized by the same method as 
described above using the PCR amplified product of the bacteriocin gene of interest as 
probes. 
The recombinant plasmids containing the correct inserts were sequenced from both 
directions using a series of designed primers based on the known nucleotide sequence 
from the flanking vector and from the insert. 
Determination of the genetic locus. The chromosomal and plasmid DNA from the 
bacteriocin producer was used to determine the genetic locus of the gene cluster 
responsible for bacteriocin production. Isolated DNA was subjected to electrophoresis 
in a 0.6% agarose gel. The DNA was blotted onto the nylon membrane and hybridized 
with the 16S rRNA gene, which was a PCR product using the primers and conditions 
described above and with a structural gene for the bacteriocin in order to differentiate 
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between chromosomal and plasmid DNA and to determine the fragment containing the 
genetic locus. 
Nucleotide and amino acid sequence analysis. The cloned nucleotide sequence 
was analyzed by Vector NTI Advance 10 (Invitrogen). The promoters for operons 
were determined by a prokaryotic promoter prediction program from Groningen 
Biomolecular Sciences and Biotechnology Institute, University of Groningen, 
Netherlands (37). The primary and secondary structure of the bacteriocin was 
analyzed by the ExPASy Proteomics System (33). 
Adsorption/desorption extraction of bacteriocin from producer cells. The 
bacteriocin was extracted by pH-dependent adsorption and desorption of the 
bacteriocin on the producer cells (40). The producer strain was grown in 1 liter of 
MRS at 30°C for 18 h until maximum bacteriocin concentration in the medium was 
observed. The pH of the culture was adjusted to 6.5 with 1M NaOH. The culture was 
heated at 70°C for 30 min to kill the producer cells. The cells were collected by 
centrifugation at 10,000 × g for 15 mins at 4°C and the supernatant was removed. The 
cells were washed twice with 5 mM sodium phosphate (pH 6.5) to remove the medium 
components. The bacteriocin was released from the cells by resuspending the cells in 
50 mL of 100 mM NaCl, pH 2.0, which was adjusted by 5% phosphoric acid. The 
solution was agitated at 4°C for 1 h. The cells were removed by centrifugation and the 
supernatant was sterilized by a 0.2 µm-sized cellulose acetate membrane and dialyzed 
in dialysis tubing (MWCO 2,000 Da, Spectrum) in 3×2 liters of Milli-Q water for 24 h 
at 4°C with stirring. The resultant solution was lyophilized overnight and reconstituted 
in 3 ml of 50 mM phosphate buffer (pH 7.0). 
Electroblotting and N-terminal sequencing of the bacteriocin. The extracted 
bacteriocin was subjected to Tricine-SDS-PAGE as described above. The bacteriocin 
in polyacrylamide gel was electroblotted onto a polyvinylidene fluoride membrane 
  68 
(Micron Separations Inc., Westborough, MA) in transfer buffer containing 10 mM 
NaHCO3, 3 mM Na2CO3, 20% methanol (11) at 100 V for 1 h at 4°C. The blotted 
bacteriocin band on the membrane was visualized by staining with 0.1% Coomassie 
Blue R-250 (Bio-Rad), 1% acetic acid, 50% methanol, and destaining in 50% 
methanol. The bacteriocin band was excised from the membrane and loaded onto a 
Perkin-Elmer sequencer (Waltham, MA) for Edman degradation (Synthesis and 
Sequencing Facility, Johns Hopkins University School of Medicine). 
RESULTS 
Identification and characterization of the bacteriocin and its producer. The 
putative bacteriocin producer was identified to be Enterococcus mundtii, designated as 
Enterococcus mundtii CUGF08, based on sequence homology of the 16S rRNA gene. 
On MRS medium, E. mundtii CUGF08 produced a typical yellow pigment that is 
distinctive from those of other Enterococcus spp (6). It is a homofermentative lactic 
acid bacterium of plant-associated sources. The putative bacteriocin produced by E. 
mundtii CUGF08 was inactivated by both of pronase E and proteinase K and was not 
affected by Tris buffer, indicating that the putative antimicrobial compound produced 
by E. mundtii CUGF08 was proteinaceous. Tricine-SDS-PAGE analysis of the 
extracted bacteriocin and overlay of the Tricine-SDS-PAGE gel with the indicator 
strain L. ivanovii, showed that the molecular weight was approximately 4,000. The 
bacteriocin was designated mundticin L. 
Antimicrobial spectrum. L. ivanovii was used as an indicator strain to titer the 
antimicrobial activity of the bacteriocin preparations since it was the most sensitive 
strain from the range of indicator bacteria strains tested. Listeria spp. were shown to 
be the most sensitive group of bacteria to mundticin L (Table 3.1), while E. faecalis 
FSL-23 140, a strain that is more related to the producer in taxonomy, was sensitive 
but much less than the Listeria spp. tested.  
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Table 3.1. Minimum inhibitory concentration of bacterial strains to mundticin L 
(AU/mL). 
 
Bacterial indicators 
 
Mundticin L 
(AU/mL) 
Incubation 
conditions for 
tested strains 
Listeria innocua  3200 TSA, 37˚C 
Listeria monocytogenes 10403S 400 TSA, 37˚C 
Listeria seeligeri 800 TSA, 37˚C 
Bacillus subtilis 1A650 256000 TSA, 37˚C 
Bacillus cereus ATCC 11778 – TSA, 37˚C 
Bacillus circulans 1473 sm – TSA, 37˚C 
Staphylococcus aureus ATCC 25923 – TSA, 37˚C 
Pseudomonas fluorescens – TSA, 37˚C 
Enterococcus faecalis FSL 23-140 6400 MRS, 30˚C 
Lactobacillus casei – MRS, 30˚C 
Lactobacillus fermentum ATCC 14931 – MRS, 30˚C 
Lactococcus lactis ATCC 11454 – MRS, 30˚C 
E. coli O157:H7 ATCC 43895 – TSA, 37˚C 
Salmonella enterica serovar Enteritidis – TSA, 37˚C 
 
However, of the various Listeria spp. tested, different species showed varied 
sensitivity to mundticin L, with L. innocua being the least sensitive and L. 
monocytogenes 10403S being the most sensitive. Gram negative strains including 
Pseudomonas fluorescens, E. coli O157:H7 ATCC 43895 and Salmonella enteritidis 
were not sensitive to mundticin L. Except for Enterococcus faecalis FSL 23-140, 
mundticin L was not active against any of the lactic acid bacteria tested which 
included L. casei, L. fermentum ATCC 14931 and the nisin A producer L. lactis spp. 
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lactis 11454. Although not potent, mundticin L showed some inhibitory activity 
against Bacillus subtilis 1A650. Bacillus cereus ATCC 11778 however, was not 
sensitive to mundticin L. 
Cloning and sequencing of the genetic determinants. Based on the acquired 
characteristics including producer identity, molecular size of the bacteriocin and its 
antimicrobial spectrum, a PCR was performed to detect the mundticin KS structural 
gene using primers Mnt-1F (5’–TGAGAGAAGGTTTAAGTTTTGAAGAA–3’) and 
Mnt-1R (5’–TCCACTGAAATCCATGAATGA–3’) and conditions described by 
Zendo et al (41). The PCR product showed a 700 bp fragment for the mundticin 
structural gene using E. mundtii CUGF08 as the template. The PCR product was 
recovered from gel and sequenced. The deduced amino acid sequence from the PCR 
product was determined to be different from that of mundticin KS. 
The genetic determinants for the bacteriocin structural and relevant genes were 
isolated by Southern blot and hybridization. A 5.5 kb KpnI and a 7.3 kb HindIII 
fragments, which contain the mundticin L structural gene, were isolated by 
hybridizing with the mundticin structural gene from the PCR described above. An 
additional 1.8 kb HindIII fragment containing the immunity gene was isolated by 
hybridizing with a probe which was the immunity gene from a PCR using primers IM-
F (5’ –GACAAGTGTGACATAATCATTG–3’) and IM-R (5’–
CAGCATTTTTAAAGATACCAAC–3’), which were designed based on the reported 
sequence of mundticin KS gene cluster (21). The PCR conditions for the immunity 
gene were the same to those identified for the mundticin KS gene except for the 
annealing temperature of 37°C. All three fragments were ligated into pUC19 and 
cloned in E. coli DH5α. The fragments were sequenced from both directions of the 
flanking DNA of pUC19 using designed primers U19F (5’–
GCCTCTTCGCTATTACGCC–3’) and U19R (5’– 
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GTTAGCTCACTCATTAGGCACC–3’), and other walking primers (data not shown) 
based on the acquired nucleotide sequence of the inserts. 
Three open reading frames (ORFs) of the relevant genetic determinants were 
identified (Figure 3.1). The first ORF (ORF1) encodes the mundticin L prepeptide, 
which consists of 58 amino acids (Figure 3.1). Following ORF1 is a putative rho-
independent terminator. ORF2 encodes a putative ATP binding cassette (ABC) 
transporter with a separate set of transcriptional elements. ORF2 is followed closely 
by ORF3 encoding for the putative immunity protein for mundticin L. ORF2 and 
ORF3 are in the same operon, sharing a common transcriptional start site and a rho-
independent terminator. No additional sequence was found to be associated with the 
production of mundticin L. 
The mature peptide of mundticin L has 43 amino acids, and two cysteine residues in 
the carboxyl terminus forming a putative disulfide bond (Figure 3.2). The calculated 
molecular weight for mundticin L is 4301.8, and the pI was 9.45. Mundticin L has a 
precursor cleavage site after the double glycine residues (Figure 3.2) and the highly 
conserved YGNGX motif in the N-terminus, both of which are typical of class IIa 
bacteriocins. However, in the YGNGX motif of mundticin L, the fifth residue was 
determined to be leucine instead of valine, the most common residue in this motif in 
class IIa bacteriocins.  
Therefore, mundticin L is a new bacteriocin with a single amino acid difference in 
the YGNGX motif compared to mundticin KS and enterocin CRL35 (27). The 
electrostatic distribution along the molecule is highly polarized with most of the 
cationic residues concentrated in the N-terminal region. The N-terminal residues at 
positions 7 to 9 (Leu-Ser-Cys) and 15 to 17 (Ser-Val-Asp) are predicted (5) to form β 
strands, followed by two α helices at positions 18 to 25 (Trp-Gly-Lys-Ala-Ile-Gly-Ile-
Ile) and 29 to 32 (Ser-Ala-Ala-Asn). 
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Figure 3.1. The operons for mundticin L production, transport, and immunity. The first 
ORF encodes the bacteriocin precursor followed by the second ORF for the putative 
ABC transporter and the third ORF for the putative immunity protein. Amino acid 
residues in single letters are given under their nucleotide sequence with the start codon 
underlined by a dotted arrow. The underlined AA sequence is the mature mundticin L. 
Boxed nucleotides are putative promoters. RBS: ribosome binding site. Sequence 
underlined by opposite arrows is a putative rho-independent terminator. 
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Besides the single amino acid difference from mundticin KS and enterocin CRL35 
in the mature peptide, the leader peptide of mundticin L has alanine and serine 
residues at positions −6 and −10, respectively, which are identical to the residues of 
enterocin CRL35 but different from the residues of mundticin KS, which are serine 
and alanine, respectively. Although the mature peptides of mundticin KS and CRL35 
are the same, the sequences of the leader peptides are different for the two bacteriocins 
(Figure 3.2). Therefore, based on amino acid sequences of the bacteriocin precursors, 
there are three different bacteriocins in the mundticin group of class IIa bacteriocins: 
mundticin L, mundticin KS (ATO6) and enterocin CRL35. 
 
 
 
 
Figure 3.2. Amino acid alignment of mundticin L, enterocin CRL35 (27), and 
mundticin KS (21). The leader peptides are in grey. The residues that are different are 
highlighted. 
 
 
 
 
Figure 3.3. Amino acid alignment of the immunity proteins for mundticin L, enterocin 
CRL 35 (27), mundticin KS (21), and mundticin (18). Different amino acid residues 
are highlighted. 
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The ABC transporter for mundticin L has 674 amino acids with 98% identity to 
those for enterocin CRL35 and mundticin KS while the length of all three sequences 
are the same. It is homologous to ABC transporters for other class IIa bacteriocins, but 
the levels of identity are less than 50% in addition to the differences in length. 
The deduced immunity protein of mundticin L was determined to be comprised of 
98 amino acids (Figure 3.3). Compared to the immunity proteins of mundticin KS and 
enterocin CRL35, the mundticin L immunity protein is the same length but it contains 
different amino acids at positions 30 (Ile), 31 (Glu), 46 (Lys) and 89 (Ile); the 
enterocin CRL35 immunity protein contains Ile, Asp, Glu and Ile, the mundticin KS 
immunity protein contains Met, Asp, Lys and Met, and Mun-im (18) contains Ile, Asp, 
Lys and Met at the same positions. 
Genetic locus of mundticin L. The structural gene of mundticin L was amplified 
by PCR and used to hybridize the chromosomal and plasmid DNA. The 16S rRNA 
gene of E. mundtii CUGF08 was used as the control. It was found that the mundticin L 
structural gene hybridized only with the plasmid DNA. Therefore, the genetic 
determinants of mundticin L are plasmid-associated. 
N-terminal sequencing of mundticin L. The N-terminus of mundticin L was 
determined to be Lys-Tyr-Tyr-Gly-Asn-Gly-Leu-Ser-Xaa-Asn, which corroborates the 
amino acid sequence deduced from the structural gene. 
DISCUSSION 
Mundticin L is a new bacteriocin that is homologous to mundticin ATO6 (KS) and 
enterocin CRL35. A unique feature of mundticin L is the single Val-to-Leu amino acid 
mutation in the YGNGV motif compared to previously identified molecules mundticin 
ATO6, mundticin KS, and enterocin CRL35. Currently, mundticin L is the first class 
IIa bacteriocin that has a single amino acid difference and the difference is located in 
the YGNGX motif at the N-terminus which is believed to be an important region for 
  75 
activity (27). The single point mutation in mundticin L may be used to examine the 
role of the amino acid mutation in the conserved motif. 
Bacteriocin 31 (34), plantaricin C19 (2) and sakacin 5x (38) belonging to class IIa 
have been reported to have the YGNGL motif but have additional mutations outside of 
the YGNGX region. The single conservative mutation in the YGNGX motif may 
provide insight into the role, if any, that residue 5 of the YGNGX motif plays in the 
activity or spectrum of activity compared to activities mundticin ATO6 (KS) and 
enterocin CRL35. Although leucine and valine have similarly hydrophobicities, 
leucine does not have the β-methyl side chain of valine, which provides a force 
restraining the freedom of the φ and ψ torsion angles and may have an effect on the 
stereostructure of the bacteriocin. Whether this type of conformational change 
phenotypically affects the thermodynamic properties of the bacteriocin (in other 
words, whether the residue mutation is redundant in structure and function) is not 
clear. The positive electrostatic potential is polarized toward the N-terminus due to the 
clustered basic amino acids in the N-terminal half of the bacteriocin, which is 
considered essential for electrostatic tethering to the cell membrane of the target cells 
(4), while the function of the YGNGX consensus is not clear. 
In this study, comparisons of the activity and the antimicrobial spectrum were 
performed for mundticin L and ATO6, but no significant differences were observed 
for either the level of activity or the spectrum of indicator bacteria tested (data not 
shown). This suggests that the fifth residue in the YGNGX complex is not essential for 
the activity of mundticin bacteriocins or that the difference in activity is not sufficient 
to be detected using traditional activity assays. Among class I bacteriocins, nisin Z 
differs from nisin A by one amino acid (Asn27His). The antimicrobial activities of 
these molecules were determined to be identical, while the diffusion rate of nisin Z is 
higher than that of nisin A (8), which should not be the case for mundticin L compared 
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to other mundticins due to the similarity of the hydrophobicities of Leu and Val. The 
three dimensional structures determined so far for leucocin A (13), carnobacteriocin 
B2 (39), Sakacin P (36) and curvacin A (17) indicates that Val is located in a β-strand-
like region of the N terminus. The positive electrostatic potential is polarized toward 
the N-terminal region, but the role of Val as a hydrophobic residue may be different. 
Although studies (19, 28) indicate that the C-terminal α-helix region may be 
responsible for the inhibitory specificity of various bacteriocins and the N terminus 
may be responsible for activity, the function of the YGNGX motif has yet to be 
clarified. 
Although mundticin L only has one residue different from other reported 
mundticins, the putative immunity protein and ABC transporter are also different in 
amino acid sequence as described above. The amino acid substitutions did not appear 
to affect the immunity of the mundticin L producer strain since the producer strain 
exhibited similar immunity levels as compared to that of the mundticin ATO6 when 
tested against itself. This suggests that the amino acid substitutions were not critical 
for the proper functioning of the immunity protein. Cross immunity tests between 
mundticin L and ATO6 did not reveal significant differences in the level of immunity 
conferred by each of the producer strains (data not shown). The difference in the 
sequences of immunity proteins is unusual compared to other identical or similar 
bacteriocins that have been identified to date. For example, pediocin PA-1 (24) and 
coagulin (23) differ by a single amino acid in the C-terminus, but their corresponding 
immunity proteins are identical. The crystal structure of the immunity protein (Mun-
im) for a recently discovered mundticin produced by E. mundtii 15-1A was resolved 
(18). Mun-im has only two different residues, at positions 31 (Asp) and 89 (Met), 
compared to the immunity protein (Figure 3.3) for mundticin L (Glu and Ile). The 
Mun-im protein is a bundle of four antiparallel α helices forming a hydrophobic core, 
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while the cationic and anionic patches are on the surface. Compared to the three-
dimensional structure of the immunity protein for enterocin A, Mun-im was found to 
have a similar tertiary structure despite their primary sequences are so different that 
the classification of these two proteins are in separate subgroups. This suggests that 
the difference in primary structure of the class IIa immunity proteins are highly 
redundant in terms of stereostructure. However, the functionality of some special 
motifs is worth noting, as the Mun-im protein indicated that the C-terminal IRYGY 
motif (Figure 3.3), which is unique for immunity proteins for the mundticin group and 
some other bacteriocins, is important for the immunity activity. 
The organization of the genetic determinants required for mundticin L production is 
similar to that of mundticin KS and enterocin CRL35. DNA sequence analysis 
suggests that the three genes are transcribed in two operons. The gene for mundticin L 
is expressed in one separate operon and the genes for immunity and ABC transporter 
are regulated in the second operon. The promoters for mundticin L precursor and for 
the second operon that contains the immunity and ABC transporter were predicted to 
be similar to the ones confirmed by Kawamoto et al (21). The genetic organization of 
the mundticin group is different from the gene clusters identified for other class IIa 
bacteriocins. For pediocin PA-1, coagulin and plantaricin 423, the genetic 
determinants required for production and secretion are clustered in a single operon 
while the genes for other bacteriocins are contained in several operons, one for 
bacteriocin precursors and their immunity, one for secretion, and/or the third one for 
regulatory elements (10). 
The genetic locus of mundticin L is plasmid-associated, which is similar to 
mundticin KS (21) and enterocin CRL35 (27). However, the non-coding DNA regions 
upstream the operons showed no homology to those of E. mundtii ATO6, CRL35 and 
NFRI 7393 (KS producer) strains. This suggests that the bacteriocin gene may have 
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different origins and may not come from a similar source with point mutations 
occurring over time. 
An initial study (13) comparing the activity of pediocin PA-1, enterocin A, sakacin 
P, and curvacin A, found that enterocin A showed the highest antimicrobial activity 
against Listeria spp. However, all four bacteriocins were found to inhibit Listeria spp. 
at a level of parts per billion (wt/vol). More extensive studies are expected to elucidate 
the difference in antimicrobial activity of various class II bacteriocins including the 
mundticin group. 
Although no listeriosis outbreaks associated with consumption of fresh alfalfa 
sprouts have been reported, food recalls have been made due to contamination of 
alfalfa sprouts with Listeria monocytogenes (16, 35). The potential risk of listeriosis 
from contaminated alfalfa sprouts cannot be underestimated. E. mundtii may have 
potential as a probiotic in select food systems and as a food-grade protective culture to 
improve safety and retard spoilage bacteria. E. mundtii CUGF08 was isolated from 
alfalfa sprouts, and its ability to grow during sprouting combined with its production 
of acid and mundticin L may prove to be useful for protecting seed sprouts by 
inhibition of the growth of foodborne pathogens that are associated with sprouts. Use 
of indigenous protective cultures isolated from sprouts to control foodborne pathogens 
may be more acceptable for sprout producers and their customers than preservatives or 
physical treatment of the finished sprouts. 
Nucleotide sequence accession number. The cloned nucleotide sequence that 
contains the genetic determinants for mundticin L has been deposited in the GenBank 
database under accession number FJ899708. 
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CHAPTER 4 
HETEROLOGOUS EXPRESSION OF THE IMMUNITY PROTEIN FOR 
MUNDTICIN L 
 
ABSTRACT 
Mundticin L, a new class IIa bacteriocin from Enterococcus mundtii CUGF08 
was characterized. Three genes associated with mundticin L production are 
organized in two operons located on a large plasmid. The gene encoding the 
bacteriocin precursor (munL) is contained in the first operon. The genes 
encoding the ABC transporter (munT) and the immunity protein (munI) are 
clustered in the second operon. The genetic organization of mundticin L and its 
homologous bacteriocins is different from other class IIa bacteriocins whose 
structural gene and immunity gene are usually organized in a single operon. 
Interestingly, deferred inhibition assay showed that the mundticin L producer 
was deficient in immunity to its own bacteriocin, which is unique and has never 
been reported for any bacteriocin. The immunity gene was amplified by PCR and 
cloned into the expression vector pMG36e. The immunity protein was expressed 
in mundticin L sensitive strains Enterococcus faecalis FSL 23-140 and Listeria 
monocytogenes 10403S to determine whether the immunity deficiency is due to 
the function of the immunity protein. The expressed immunity protein rendered 
FSL 23-140 and 10403S less sensitive to mundticin L but full immunity was not 
observed, suggesting that the immunity protein does not provide full protection. 
Additional factors could be involved in this unusual phenotype. 
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INTRODUCTION 
Bacteriocins are ribosomally synthesized antimicrobial peptides that inhibit related 
bacteria (8). Bacteriocins, especially those from lactic acid bacteria (LAB), are 
promising for food applications due to their “natural” character and safety for human 
consumption. The genetic determinants for class I and class II bacteriocins contain at 
least two genes: a gene for the bacteriocin precursor and a gene for the corresponding 
immunity protein. Additional genes may be included for transport, regulation and 
modification. However, for most bacteriocins, the genes for the bacteriocin precursor 
and the immunity protein are clustered together in a single operon. Concomitant 
transcription of these two genes may produce equal amounts of the bacteriocin and 
immunity protein so that sufficient amount of the immunity protein can protect the 
producer organism from being killed by its own bacteriocin. However, a recently 
identified group of mundticins have a unique genetic organization (2, 4, 7, 11). The 
gene encoding for the mundticin precursor is contained in one operon while the genes 
for the ABC transporter and immunity are separately organized in a downstream 
operon. This genetic arrangement raises the question of how the transcription of these 
three genes is coordinated to ensure functional immunity to provide the producer 
organism protection against the bacteriocin it produces. 
Interestingly, we found that the mundticin L producer Enterococcus mundtii 
CUGF08 was deficient in immunity to its own bacteriocin. This phenotype is atypical 
and has never been reported for any bacteriocin. As an initial step toward full 
understanding of its molecular mechanism, the gene for the immunity protein was 
cloned into a Gram-positive-negative shuttle vector pMG36e and expressed in 
sensitive strains to determine if the immunity deficiency is due to the function of the 
immunity protein. 
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MATERIALS AND METHODS 
Cultures and media. The strains and plasmids used are included in Table 4.1.  
 
Table 4.1. Strains, plasmids, and primers used in this study. 
 
Strains, plasmids 
 and primers 
Description References 
Strains   
E. coli DH5α 
F- φ80lacZ∆M15 ∆(lacZYA-argF) U169 recA1 
endA1 hsdR17 (rk-, mk+) gal- phoA supE44 λ- thi-1 
gyrA96 relA1 
Invitrogen 
E. faecalis FSL 23-
140 
Food isolate, sensitive to mundticin L Lab strain 
E. faecalis FSL 23-
140A 
Strain containing the plasmid pGF09 This study 
L. monocytogenes 
10403S 
Food isolate, sensitive to mundticin L Lab strain 
L. monocytogenes 
10403SA 
Strain containing the plasmid pGF09 This study 
Listeria ivanovii Indicator strain for bacteriocin activity assay Lab strain 
E. mundtii CUGF08 Mundticin L producer (4) 
E. mundtii ATO6 Mundticin ATO6 producer (2) 
Plasmids   
pMG36e Expression vector, Em
r
, 3.6 kb (14) 
pGF09 
pMG36e containing 312-bp XbaI-HindIII fragment of 
the immunity gene amplified by primers IMP-F and 
IMP-R, Em
r
, 3.9 kb 
This study 
Primers   
IMP-F 5’-GAGGATCTAGAGATGAGTAATTTAAAG-3’ This study 
IMP-R 5’-GAATAAAAGCTTCACTAATATCCATATC-3’ This study 
36E-F 5’-CATCCTCTTCGTCTTGGTAGC-3’ This study 
36E-R 5’-GAACCTCAACTCCAAATATCGTAG-3’ This study 
Col-F 5’-GTAATCAGCAAGCGATATAC-3’ This study 
Col-R 5’-GCTTCACTAATATCCATATC-3’ This study 
 
    E. coli DH5α was cultured in Luria-Bertani (LB) broth or on LB agar (Difco, 
Becton Dickinson and Company, Sparks, MD). LB agar and broth, both containing 
200 µg/mL of erythromycin (Fisher Scientific, Fair Lawn, NJ), were used as a 
selective medium to screen for clones and as a medium to culture transformed E. coli 
DH5α cells for plasmid preparation, respectively. MRS broth or agar (Criterion, Santa 
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Maria, CA) were used for Enterococcus mundtii CUGF08, E. mundtii ATO6, E. 
faecalis FSL 23-140 and Enterococcus faecalis FSL 23-140A. Listeria monocytogenes 
10403S and L. monocytogenes 10403SA were cultured in Brain Heart Infusion (BHI) 
broth or on BHI agar. Erythromycin (5 µg/mL) was used for MRS agar/broth and BHI 
agar/broth to screen for clones and culturing transformed strains for plasmid extraction. 
Enterococcus spp. cultured in MRS broth were incubated at 30°C without shaking. L. 
monocytogenes and E. coli DH5α were incubated at 37°C with shaking at 225 rpm 
except for cultures for plasmid preparation from E. coli DH5α which were incubated 
at 37°C with 300 rpm of shaking. 
Titration of the sensitivity of wild type and immunity protein-expressing 
strains.  Mundticin L was isolated and concentrated by a previously described pH-
dependent extraction method (4). Spot diffusion assay (12) was used to titer 
bacteriocin activity. Prepared bacteriocin solution was subjected to two-fold dilutions 
in sodium phosphate buffer (pH 7.0, 50 mM) and 10 µL of each dilution were spotted 
onto a lawn of Listeria ivanovii. The lawn was prepared by overlaying 8 mL of TSB 
soft agar (0.75% wt/vol) which was inoculated with 50 µL of 18-h cultured L. ivanovii. 
The antimicrobial activity (AU/mL) was defined as the reciprocal of the highest 
dilution showing definite inhibition in the indicator lawn. Spot diffusion assay was 
also used to titer the sensitivity of wild type and transformed E. faecalis FSL 23-140 
and L. monocytogenes 10403S strains. An adapted well diffusion assay was used to 
compare the sensitivities of these strains. Mundticin L (320 AU) was loaded to wells 
(6 mm in diameter) in agar plates. After drying, the plates were overlaid by the same 
method described above. Proteinase K (100 µg) was added to exclude the possibility 
of non-bacteriocin antimicrobial effects. 
Construction of the expression vector. The immunity gene was amplified from 
the genomic DNA of E. mundtii CUGF08 using primers IMP-F and IMP-R (Table 
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4.1), which contained flanking XbaI and HindIII restriction sites, respectively. The 
amplified fragment and the expression vector pMG36e were digested with XbaI and 
HindIII restriction enzymes and cloned into the XbaI and HindIII sites of pMG36e. 
The recombinant pMG36e was transformed into E. coli DH5α by electroporation at 
2.0 kV, 200 Ω and 25 µF. The vector was isolated and transformed into the sensitive 
strains E. faecalis FSL 23-140 and L. monocytogenes 10403S by electroporation. For 
transformation, electrocompetent E. faecalis FSL 23-140 cells were prepared by 
growing cells in 4% (wt/vol) glycine according to the method described by Shepard et 
al., (13); electrocompetent L. monocytogenes 10403S cells were made by treatment 
with 10 µg/mL of penicillin G (Sigma, St. Louis, MO) (10). Electroporation (Gene 
Pulser II, Bio-Rad, Hercules, CA) was used to introduce the expression vector. Prior to 
electroporating the recipient strains, sequencing of the insert from the flanking regions 
of pMG36e with primers 36E-F and 36E-R (Table 4.1) was done to ensure that the 
sequence and reading frame of the insert was correct. The expression of the immunity 
gene was confirmed by plasmid profiling, sensitivity testing to mundticin L, and PCR 
amplification of the immunity gene using primers Col-F and Col-R. 
The genomic DNA of E. mundtii CUGF08 was isolated by a chloroform/phenol 
extraction method (9). Plasmids from E. mundtii CUGF08 were isolated by a rapid 
lysis method (1). The expression vector pMG36e and the subsequent recombinant 
plasmid pGF09 were isolated from E. coli DH5α using a plasmid mini kit (Qiagen, 
Germantown, MD) according to the procedures described by the manufacturer. The 
expression vector pGF09 from E. faecalis FSL 23-140A and L. monocytogenes 
10403SA was isolated by the Qiagen mini kit with adjustment: lysozyme (Sigma) and 
mutanolysin (Sigma) were added to resuspension buffer to concentrations of 5 mg/mL 
and 15 U/mL, respectively (5). PCR reactions were performed in a RoboCycler 
(Stratagene, La Jolla, CA) at annealing temperature of 37°C for 30 reactions. 
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Restriction enzymes were supplied by Fisher Scientific. All oligonucleotides were 
synthesized and supplied by Integrated DNA Technologies (Coralville, IA). 
Nucleotide sequencing was performed at Cornell University Life Sciences Core 
Laboratories. 
RESULTS AND DISCUSSION 
Heterologous expression of the immunity protein. The mundticin L producer E. 
mundtii CUGF08 displayed an immunity deficiency to its own bacteriocin. When 320 
AU of mundticin L was added to a 6-mm well in MRS agar, a clear inhibition zone 
against E. mundtii CUGF08 was observed (Figure 4.1A). Proteinase K digested the 
bacteriocin and the producer was not inhibited (Figure 4.1B). This suggests that the 
producer is naturally deficient in immunity to mundticin L. This phenotype has not 
been reported for any bacteriocin. Agar diffusion assay of mundticin ATO6, a similar 
bacteriocin produced by E. mundtii ATO6 (2), showed that ATO6 also lacked 
immunity to its bacteriocin (data not shown). Therefore, the immunity deficiency 
appears to be unique to the mundticin producers. 
Heterologous expression of the immunity protein for mundticin L was performed to 
determine whether the immunity deficiency was due to the function of the immunity 
protein or additional extraneous host factors such as endogenous proteases. The gene 
encoding the immunity protein was transcriptionally and translationally fused into the 
multiple cloning site of pMG36e. The protein was successfully expressed in sensitive 
strains of L. monocytogenes 10403S and E. faecalis FSL 23-140, as confirmed by 
plasmid profiling and phenotypic change of the sensitivity of the transformed strains. 
Transformed strains of L. monocytogenes 10403SA and E. faecalis FSL 12-140A that 
expressed the immunity protein displayed less sensitivity compared to that of the wild 
type strains at the same mundticin L concentrations (Figure 4.1C, D, E and F). Slightly 
smaller inhibition zones were observed with strains 10403SA and FSL 12-140A.  
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Figure 4.1. Sensitivity of different strains to mundticin L. Each well was loaded with 
320 AU mundticin L. E. mundtii CUGF08 was deficient in immunity to its own 
bacteriocin (A) while self-inhibition disappeared after adding proteinase K (100 µg) to 
the well (B); Sensitivity of the wild type E. faecalis FSL 23-140 (C), L. 
monocytogenes 10403S (E) and the immunity protein-expressing strains FSL 23-140A 
(D) and 10403SA (F) were similar. However, titration of the sensitivity of wild type 
and transformed strains was different (see Table 4.2).  
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However, both strains still remained sensitive to mundticin L. It is clear that the 
difference in the size of inhibition zones displayed by the wild type and immunity-
expressing strains was not significant, suggesting the immunity protein did not provide 
full protection for the sensitive strains. 
Titration of the sensitivity of wild type and immunity protein-expressing 
strains. To quantitatively differentiate wide type and immunity-expressing strains, the 
sensitivity of these strains was titrated using the spot diffusion assay (Table 4.2). L. 
monocytogenes 10403SA was determined to be four times less sensitive to mundticin 
L than the wild type strain while E. faecalis FSL 23-140A was two times less sensitive 
than the wild type strain. The observed difference in sensitivity confirmed the function 
of the immunity protein. However, the immunity protein conferred only partial 
protection to the sensitive strains tested. 
 
 
Table 4.2. Minimum inhibitory concentration of wild type and immunity protein-
expressing strains to mundticin L. 
 
Bacterial strains Sensitivity (AU/mL) 
E. faecalis FSL 23-140 1600 
E. faecalis FSL 23-140A 3200 
L. monocytogenes 10403S 400 
L. monocytogenes 10403SA 1600 
 
Heterologous expression of the immunity protein for mundticin L showed that the 
immunity protein did not confer full protection to sensitive strains, suggesting that the 
protein may function in a similar manner as that in the producer organism E. mundtii 
CUGF08. However, E. mundtii CUGF08 is capable of growing to typical high cell 
densities in liquid culture such us MRS broth (data not shown), suggesting that the 
growth of the producer organism was not inhibited by the production of mundticin L 
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in liquid culture. Certain unknown molecular factors may diffuse more readily to be 
accessible to planktonic cells in liquid culture while their diffusion could be limited 
due to the character of the agar medium. Additional uncharacterized factors may be 
involved in immunity to mundticin L. Therefore, E. mundtii CUGF08 must have a 
mechanism to protect itself from being killed by its bacteriocin. This mechanism may 
involve multiple factors besides the immunity protein.  Random mutagenesis of the 
wild type strain may elucidate additional genes involved in mundticin L immunity 
responsible for this unique phenotype. 
It should be noted that the immunity gene in the pMG36e was a translational fusion; 
i.e. the product of translation may contain additional N-terminal residues that are 
encoded by the upstream fragment of the expression vector. Therefore, the N-terminal 
residues in addition to the 98 amino acids in the original immunity protein might have 
an effect on the phenotypes of the strains 10403S and FSL 23-140A. However, it 
should not be a determining factor in immunity because the expression of bacteriocin 
immunity proteins by translationally fusing into the promoter region and translational 
start codon of pMG36s has been studied before (5, 6).  These studies similarly fused 
the immunity gene into the same reading frame of pMG36e. The immunity proteins 
were successfully expressed and conferred full immunity to sensitive strains. 
Therefore, the N-terminal fusion should not be a determining factor for the immunity 
phenotype in the transformed strains from this study. 
The genes for mundticin L immunity protein and mundticin L structural gene were 
contained in separate operons, which is unique for mundticin L, KS, ATO6 and 
Enterocin CRL35. This unique genetic organization was confirmed by a 
transcriptional study of mundticin KS (7). This lack of translational coupling raises the 
question as to how expression of the bacteriocin and the immunity protein are 
coordinated at the transcription level to ensure that sufficient levels of the immunity 
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protein are produced for full immunity. It may be possible that the immunity 
deficiency was due to the unbalanced expression of these two genes. As a possible 
means to determine this, engineered expression vectors may be constructed with both 
genes in a single operon, in order to determine whether the immunity deficiency was 
due to differing levels of mundticin L and its immunity protein. Initial attempts for the 
proposed construct using pGKV259 (15) were unsuccessful. Unfortunately, the 
cloning host E. coli DH5α containing the constructed vector could not grow well (data 
not shown), possibly due to the intracellular toxicity generated by the expressed 
bacteriocin. Evaluation of the mundticin L and immunity gene transcripts will confirm 
whether the expected transcript and expression levels are being synthesized. 
However, additional factors may be involved in the immunity deficiency. An 
investigation of the man-PST operon in E. mundtii CUGF08 and its expression level 
may be worthwhile since high level of expression may result in producer sensitivity to 
mundticin L (3). A genome-wide mutagenesis may be the best strategy to identify 
potential additional genetic factors for this interesting phenotype. 
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CHAPTER 5 
BACTERIOCINOGENIC LACTIC ACID BACTERIA AS BIOLOGICAL 
CONTROL AGENTS TO ENHANCE THE SAFETY OF SPROUTS 
 
ABSTRACT 
Alfalfa sprouts are a well known food vehicle for human pathogens and have 
been responsible for numerous foodborne illness outbreaks. A biological control 
strategy using food-grade protective cultures may be promising in preventing 
pathogens from rapidly growing to high levels during sprouting. Unlike single-
step treatment with surface sanitizers such as calcium hypochlorite which may 
allow survival of pathogens trapped inside of the seeds and thus rapid growth 
during subsequent sprouting process, protective cultures provide sustainable 
antimicrobial effect during the whole process of sprouting by acid production, 
bacteriocin and exclusive competition for growth. Enterococcus mundtii CUGF08 
and Lactococcus lactis AA4 are two bacteriocinogenic lactic acid bacteria (LAB) 
isolated from alfalfa sprouts. E. mundtii CUGF08 produces mundticin L, a class 
IIa bacteriocin which has especially high antimicrobial activity against Listeria 
spp. L. lactis AA4 produces nisin Z. These two lactic acid bacteria were 
inoculated to alfalfa seeds which were pre-inoculated with different levels of 
Salmonella enterica, L. monocytogenes and Escherichia coli O157:H7. The growth 
of E. mundtii CUGF08, L. lactis AA4, S. enterica, L. monocytogenes and E. coli 
O157:H7 on alfalfa sprouts were monitored over the course of sprouting. Both 
isolates controlled the growth of pathogens to a significant extent. In general, L. 
lactis AA4 showed a higher efficacy than E. mundtii CUGF08 for controlling the 
growth of L. monocytogenes and S. enterica, and lower inhibition against E. coli 
O157:H7. 
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INTRODUCTION 
Alfalfa sprouts have been associated with many foodborne illness outbreaks around 
the world. Contaminated seeds have been identified as the source for most of the 
reported outbreaks (10). A systematic approach with multiple hurdles for the entire 
sprout production process could be an effective strategy for reducing the risks of 
sprout-associated outbreaks. This approach would integrate good agricultural practices 
(GAP) to reduce contamination of seeds pre-harvest, seed decontamination methods to 
eliminate pathogens from contaminated seeds and/or sprout treatment to 
decontaminate sprouts during the sprouting process. Seed treatment is the preferred 
strategy compared to sprout treatment because the contamination levels are lower in 
the seeds and an organoleptic change in the finished sprouts is less likely. Many 
studies have investigated physical, chemical, and biological intervention methods to 
decontaminate or eliminate pathogens from alfalfa seeds. None of the seed treatment 
methods have been shown to be effective in eliminating pathogens from seeds (> 5-log) 
without compromising the seed viability. Although FDA currently recommends seeds 
be treated in 20,000 ppm calcium hypochlorite to mitigate the situation, evidence has 
shown that outbreaks have been linked to seeds that were treated by this method (14). 
Alfalfa seeds are relatively small and thus higher in surface area than other types of 
seeds, such as mung bean. The surface of seeds has crevices and wrinkles where 
pathogens can be trapped inside and become inaccessible to surface sanitizers (5). 
These special structures may explain why alfalfa seeds are the main type of seeds that 
have been associated with foodborne illness outbreaks. Therefore, development of 
decontamination methods whose efficacy is not limited by the surface structure of 
seeds is needed. Among them, physical methods such as thermal treatment and high 
pressure that can inactivate pathogens regardless of seed structure have shown 
potential (2, 9, 11, 12). 
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Biological control of pathogen growth during sprouting may have potential since 
the antimicrobial effect due to acid and bacteriocin production, and competitive 
exclusion would be sustainable during the whole process of sprouting. Since 
protective cultures exert antimicrobial effects during seed sprouting, they may inhibit 
pathogens regardless of seed structures. Although we have shown that thermal 
treatment of alfalfa seeds may achieve 5-log reduction without significantly reducing 
germination rates of alfalfa seeds (6), post-processing contamination during sprouting 
may pose additional risks. A few studies have investigated the effectiveness of 
potential protective cultures in inhibiting pathogens on alfalfa sprouts. Plant-
associated Pseudomonas fluorescens 2-79 was shown to successfully control the 
growth of S. enterica strains on alfalfa sprouts for the first 6 days of sprouting (8). 
However, the effect of this organism on E. coli O157:H7 was not investigated despite 
it has been responsible for numerous sprout associated foodborne illness outbreaks. 
Although pseudomonads are part of the natural microbiota in sprouted seeds, the use 
of pseudomonads as protective cultures may be controversial due to their non-food-
grade status. Lactic acid bacteria would be the best applicable protective cultures due 
to their generally recognized as safe (GRAS) status and their potential in antibiosis. E. 
mundtii ATO6 produces mundticin ATO6 which is a class IIa bacteriocin that exhibits 
high inhibitory activity against L. monocytogenes (4). The potential of E. mundtii 
ATO6 and two additional bacteriocinogenic Pediococcus parvulus strains as 
protective cultures to control the growth of L. monocytogenes in mung bean sprouts 
has been investigated (3). The specific growth rate of E. mundtii ATO6 was higher 
than that of Pediococcus parvulus under modified atmosphere storage with elevated 
CO2. However, at refrigeration temperatures the growth of L. monocytogenes on mung 
bean sprouts was not inhibited by E. mundtii ATO6. The growth control of E. mundtii 
ATO6 on L. monocytogenes, Salmonella spp. and E. coli O157:H7 during sprouting 
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was not studied. The inhibitory effect of Lactococcus lactis on the growth of L. 
monocytogenes during sprouting of alfalfa seeds was studied (13). Although L. lactis 
showed significant inhibition on L. monocytogenes compared to the control, the 
pathogen levels on growing sprouts was still higher than the initial inoculation level. 
Lactic acid bacteria have also been isolated from alfalfa sprouts and screened for 
antagonism against relevant pathogens associated with sprouts (17). Lactococcus 
lactis subsp. lactis was shown to be the most effective isolate for inhibiting L. 
monocytogenes, Salmonella spp. and E. coli O157:H7. Although L. lactis showed 
significant inhibition on all three pathogens, the study was performed in model 
systems rather than on growing sprouts. 
Although the aforementioned studies investigated the potential of LAB such as L. 
lactis, E. mundtii and Pediococcus parvulus as biocontrol agents to enhance sprout 
safety, none of them studied their efficacy on all three relevant pathogens with 
growing alfalfa sprouts. Research endeavors have been focused on the biocontrol of L. 
monocytogenes which is less of a concern for sprout safety. Moreover, most studies 
used LAB that were isolated from other sources rather than LAB species that are part 
of the natural microbiota of seed sprouts. Application of sprout-associated LAB 
isolates for sprouts as protective cultures may be more acceptable by consumers and 
also effective in inhibiting relevant pathogens due to their possible physiological and 
genetic adaptation to sprouts. We isolated two bacteriocinogenic lactic acid bacteria 
strains from fermented alfalfa sprouts: E. mundtii CUGF08 and L. lactis AA4. E. 
mundtii CUGF08 produces mundticin L, an anti-Listeria bacteriocin which has been 
characterized in a previous study (7); L. lactis AA4 produces nisin Z. Nisin Z and 
mundticin L are typical bacteriocins representing class I and class IIa bacteriocins, 
respectively. This study investigated the potential of these two bacteriocinogenic LAB 
as biological control agents to inhibit the growth of L. monocytogenes, S. enterica and 
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E. coli O157:H7 on growing alfalfa sprouts. 
MATERIALS AND METHODS 
Cultures and media. Two LAB strains isolated from fermented alfalfa sprouts (2% 
NaCl and reduced oxygen environment) were used as protective cultures: E. mundtii 
CUGF08 and L. lactis AA4. E. mundtii CUGF08 is a mundticin L-producer which was 
described in a previous study (7); L. lactis was found to produce nisin Z which was 
identified by PCR and sequencing of the nisin gene using primers and reaction 
conditions described elsewhere (16). The isolated strains were identified by 
sequencing amplified 16S rRNA genes and homology analysis using the BLAST 
program described previously (7). A cocktail of five strains of L. monocytogenes, E. 
coli O157:H7, and five serovars of S. enterica were used for inoculation of alfalfa 
seeds. The detailed information about the bacterial strains used in this study was 
included in Table 5.1. To facilitate enumeration of S. enterica and E. coli O157:H7, all 
ten strains were transformed with pGFP (Clontech Laboratories, Palo Alto, CA), a 
plasmid encoding a green fluorescent protein and ampicillin resistance. Cultures were 
stored at -80°C in respective media containing 15% glycerol. 
To prepare the inocula, L. monocytogenes strains were grown in brain heart infusion 
(BHI) broth (Difco, Becton Dickinson and Company, Sparks, MD). Tryptic soy broth 
(TSB) (Criterion, Santa Maria, CA) supplemented with 100 µg/ml of ampicillin 
(Fisher Scientific, Fair Lawn, NJ) was used to culture S. enterica and E. coli O157:H7 
for the inoculated studies. All pathogens were grown at 37°C with shaking at 225 rpm 
(Innova 4230, New Brunswick Scientific, Edison, NJ). MRS broth (Criterion) was 
used to culture E. mundtii CUGF08 and L. lactis AA4 at 30°C without aeration. 
For microbiological enumeration of the inoculated alfalfa seeds and sprouts, Oxford 
medium base with Oxford antimicrobial supplement (Difco) was used to culture  
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Table 5.1. Bacterial strains used in this study. 
 
Bacterial strains Description Sources 
L. lactis AA4 Protective culture, nisin z 
producer 
Isolate from alfalfa 
sprouts 
E. mundtii CUGF08 Protective culture, mundticin L 
producer 
Isolate from alfalfa 
sprouts 
L. ivanovii Indicator strain for bacteriocin 
activity assay 
Lab strain 
L. monocytogenes 19112 Pathogen for inoculation M. Wiedmann, 
Cornell University 
L. monocytogenes 1043S Pathogen for inoculation M. Wiedmann, 
Cornell University 
L. monocytogenes F8027 Pathogen for inoculation M. Wiedmann, 
Cornell University 
L. monocytogenes F8309 Pathogen for inoculation M. Wiedmann, 
Cornell University 
L. monocytogenes J1-119 Pathogen for inoculation M. Wiedmann, 
Cornell University 
S. enterica Montevideo Pathogen for inoculation, 
harboring pGFP with Amp
r
 
Lab strain 
S. enterica Gaminara Pathogen for inoculation, 
harboring pGFP with Amp
r
 
Lab strain 
S. enterica Rubislaw Pathogen for inoculation, 
harboring pGFP with Amp
r
 
Lab strain 
S. enterica Hartford Pathogen for inoculation, 
harboring pGFP with Amp
r
 
Lab strain 
S. enterica Typhimurium Pathogen for inoculation, 
harboring pGFP with Amp
r
 
Lab strain 
E. coli O157:H7 ATCC 35150 Pathogen for inoculation, 
harboring pGFP with Amp
r 
Clinical isolate (J. 
Russell, Cornell 
University) 
E. coli O157:H7 ATCC 43895 Pathogen for inoculation, 
harboring pGFP with Amp
r
  
Raw Hamburger 
meat isolate (M. P. 
Doyle, University of 
Georgia) 
E. coli O157:H7 933 Pathogen for inoculation, 
harboring pGFP with Amp
r
  
Raw Hamburger 
meat isolate (M. P. 
Doyle, University of 
Georgia) 
E. coli O157:H7 ATCC 43894 Pathogen for inoculation, 
harboring pGFP with Amp
r
  
Clinical isolate (M. 
P. Doyle, University 
of Georgia) 
E. coli O157:H7 ATCC 43889 Pathogen for inoculation, 
harboring pGFP with Amp
r
  
Clinical isolate (M. 
P. Doyle, University 
of Georgia) 
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L. monocytogenes. Tryptic soy agar (TSB containing 1.5% agar) with 100 µg/ml of 
ampicillin was used for culturing S. enterica and E. coli O157:H7. E. mundtii 
CUGF08 was grown on MRS agar containing 0.02% (wt/vol) sodium azide (Sigma, St. 
Louis, MO) for samples inoculated with L. monocytogenes or on enterococcosel agar 
(EA) for samples inoculated with S. enterica or E. coli O157:H7. L. lactis AA4 was 
grown on Alsan agar which is a highly selective medium for L. lactis subsp. lactis and 
was prepared according to the procedures described by Alzoreky et al (1). 
Inoculation of alfalfa seeds with pathogens and protective cultures. Alfalfa 
seeds (Lucerne) were supplied by Sringwater Sprouts, Honeoye Falls, NY. Protective 
cultures were inoculated to alfalfa seeds which were pre-inoculated with L. 
monocytogenes, S. enterica, or E. coli O157:H7. The artificially contaminated seeds 
were subjected to four treatments with protective cultures: single culture of E. mundtii 
CUGF08, single culture of L. lactis AA4, co-culture of E. mundtii CUGF08 and L. 
lactis AA4, and the control (no inoculation of either culture). 
For inoculation of alfalfa seeds with pathogens at high levels, L. monocytogenes 
strains were grown in 5 ml of BHI broth to log phase (OD600nm=0.9) for 18 h. One 
milliliter of each strain was centrifuged at 6000 ×g at 4°C for 10 min. The cells were 
washed once with 1 ml of sterile Milli-Q water and resuspended in sterile Milli-Q 
water to remove any growth media and by-products. The resuspended cells were 
combined to make a 5 ml of cocktail L. monocytogenes and mixed by low-speed 
vortexing. One milliliter of the mixed cocktail was diluted 1,000 fold and five 
milliliters of the highest dilution was added to 1 kg of alfalfa seeds combined with 1.5 
L sterile Milli-Q water. The seeds were soaked for 20 min with agitation to ensure 
even inoculation. The seeds were transfer to multiple layers of sterile cheese cloth on 
top of two sterile wire racks (0.2 m
2
 total in area) and dried for 24 h in a biological 
safety cabinet. To prepare inocula of S. enterica and E. coli O157:H7, the same 
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procedure was used except the growth medium was TSB supplemented with 
ampicillin. 
To prepare inocula of protective cultures, E. mundtii CUGF08 and L. lactis AA4 
were grown in 5 ml of MRS broth for 8 h. One milliliter of each culture was separately 
inoculated into duplicate 250 ml of MRS broth and incubated for 16 h to log phase 
(OD600nm=0.6). The cells were centrifuged at 6000 ×g at 4°C for 15 min and washed 
once in an equal volume of Milli-Q water. The washed cells were resuspended in 200 
mL of water and combined to a final volume of 400 ml for each culture. Alfalfa seeds 
that were pre-inoculated with L. monocytogenes, S. enterica, or E. coli O157:H7 were 
inoculated with single bioprotective culture of E. mundtii CUGF08, L. lactis AA4, or 
mixed cultures of both. To inoculate seeds with a single culture, 200 ml of E. mundtii 
CUGF08 or L. lactis AA4 resuspended cells were mixed with 250 ml Milli-Q water to 
make 450 ml total and approximately 200 g of artificially contaminated seeds. For co-
culture inoculation, 200 ml of E. mundtii CUGF08 and L. lactis AA4 were combined 
and mixed with 50 ml of sterile Milli-Q water to make a 450 ml mixture that was 
mixed with approximately 200 g of contaminated seeds. For the control, 450 ml of 
sterile Milli-Q water was mixed with 200 g of contaminated seeds. All mixtures were 
agitated occasionally for 20 min at room temperature (22 ± 2°C). 
Germination of alfalfa seeds. Approximately 50 g of freshly inoculated alfalfa 
seeds from each of the four treatments was transferred to a sterile aluminum tray 
[0.527 m (L) × 0.325 m (W) × 0.086 m (H)] (BJWC, Natick, MA). The trays were 
lined with a layer of urethane foam (Carpenter Co., Russellville, KY) and a sheet of 
filter paper (3M filter paper; Fisher Scientific) on top. The seeds were spread evenly to 
a single layer over the filter paper and covered with aluminum foil. The trays were 
incubated at 30°C for 4 days. Except for day 0, sprouting seeds in each tray were 
sprayed with 20 ml of sterile Milli-Q water once a day using a plant sprayer (Misco 
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Enterprises, Dunellen, NJ) right after sampling for bacterial analysis. 
Bacterial analysis. Growth of pathogens and bioprotective cultures were monitored 
on alfalfa seeds and sprouts during the sprouting process from day 0 to day 4. 25 g of 
seeds or sprouts were sampled for bacterial analysis. Seeds or sprouts were diluted 10 
fold with 0.1% (wt/vol) sterile peptone (Difco) water and stomached at 260 rpm by a 
stomacher (Stomacher 400, Seward Ltd., Basingstoke, UK) for 1 min. Stomached 
samples were subjected to a series of 10-fold dilution in sterile peptone water. 
Selected dilutions were surface-plated onto selective media. Oxford medium base plus 
antimicrobial supplement was used to select for L. monocytogenes. TSA plus 
ampicillin was used for S. enterica and E. coli O157:H7. Alsan medium was used to 
select for L. lactis subsp. lactis. EA was used to select for Enterococcus spp. except 
for the seeds pre-inoculated with L. monocytogenes which can grow along with 
Enterococcus spp. on this medium. Instead, MRS plus 0.02% sodium azide was used 
to estimate E. mundtii CUGF08 when seeds were inoculated with L. monocytogenes. 
All media were tested for their growth selectivity of the intended microorganism. 
Oxford medium and MRS plus sodium azide were incubated at 30°C for 48 h prior to 
enumeration. EA and TSA plus ampicillin were incubated at 37°C for 24 h. Alsan 
medium was incubated at 30°C for 48 h in anaerobic jars (Difco). GasPak EZ 
Anaerobe Container System and catalyst (Becton Dickinson and Company, Sparks, 
MD) were placed in the jars to produce anaerobic conditions which were monitored by 
the inclusion of an anaerobic indicator (Oxoid, Hants, United Kingdom). 
Bacteriocin activity assay and pH of finished sprouts. Bacteriocin activity of the 
sprouts was measured using a spot diffusion assay (15). Finished sprouts were 
sampled, diluted 10 fold and stomached as described above. The mixed solution was 
subjected to 2-fold dilutions in sodium phosphate buffer (pH 7.0, 50 mM) and 10 µL 
of each dilution was spotted onto a lawn of Listeria ivanovii, the sensitive bacteriocin 
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indicator strain. The lawn was prepared by overlaying 8 mL of TSB soft agar (0.75% 
wt/vol) which was inoculated with 50 µL of 18-h cultured L. ivanovii. The 
antimicrobial activity (AU/mL) was defined as the reciprocal of the highest dilution 
showing definite inhibition in the indicator lawn. The pH was measured on day 4. 25 g 
of sprouts were diluted 10 fold and stomached prior to pH measurement (Orion 2 Star, 
Thermo Scientific, Waltham, MA). 
Statistics. All four treatments were performed in triplicate. Bacterial analysis was 
performed in duplicate plating for each trial. The data points are presented as averages 
of three trials. JMP 8.0 (SAS, Cary, NC) was used to perform statistical analysis. Type 
I error (P) was 0.05 by default. 
RESULTS AND DISCUSSION 
Inhibition of pathogens on alfalfa sprouts by protective cultures. When singly 
inoculated onto alfalfa seeds, both E. mundtii CUGF08 and L. lactis AA4 significantly 
inhibited the growth of L. monocytogenes compared to the control (Figure 5.1). 
However, L. lactis AA4 showed greater inhibition of L. monocytogenes growth 
compared to that observed with E. mundtii CUGF08. When both AA4 and CUGF08 
were inoculated onto alfalfa seeds, the inhibition of L. monocytogenes was similar to 
that of single inoculation of AA4, suggesting that a synergy of AA4 and CUGF08 is 
not readily apparent. In the control, L. monocytogenes rapidly grew from 5-log CFU/g 
to higher than 8-log CFU/g within 24 h of sprouting without any protective cultures. 
Although L. lactis AA4 and the combination of protective cultures slowed the growth 
of L. monocytogenes, the level of the pathogen on the finished sprouts was still greater 
than 1-log higher than the initial inoculation level. 
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Figure 5.1. Growth of Listeria monocytogenes on alfalfa sprouts inoculated with 
Lactococcus lactis AA4, Enterococcus mundtii CUGF08, both, and none (control). 
 
 
The growth of S. enterica was inhibited by both protective cultures (Figure 5.2). 
Either single inoculation of E. mundtii CUGF08 or L. lactis AA4, or both, controlled 
the growth of S. enterica to a significant extent, but less pronounced than L. 
monocytogenes. Unlike what was observed with bio-control of L. monocytogenes, co-
inoculation of both protective cultures showed the most significant inhibition with S. 
enterica compared to the single inoculation of either culture. Single inoculation of L. 
lactis AA4 inhibited S. enterica more than that observed with E. mundtii CUGF08 
inoculated seeds. When compared to the control, which maintained the highest level of 
S. enterica on sprouts, E. mundtii CUGF08 still showed significant growth inhibition 
of S. enterica. Single inoculation of L. lactis AA4 or co-inoculation with E. mundtii 
CUGF08, allowed for an increase of greater than 1-log of S. enterica levels, while the 
control with no protective cultures added, allowed for S. enterica to increase by more 
than 2-logs. 
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Figure 5.2. Growth of Salmonella enterica on alfalfa sprouts inoculated with 
Lactococcus lactis AA4, Enterococcus mundtii CUGF08, both, and none (control). 
 
Although the inoculation level of E. coli O157:H7 on alfalfa seeds was slightly 
lower than the other two pathogens tested, E. coli O157:H7 grew to a comparable 
level within the first 24 h on seeds that were not inoculated with any protective 
cultures (Figure 5.3). Neither single culture of L. lactis AA4 nor co-culture controlled 
the growth of the pathogen whose levels were even higher than the control. However, 
E. mundtii CUGF08 showed the most significant inhibition of E. coli O157:H7 from 
day 2 to day 4. The finished sprouts inoculated with E. mundtii CUGF08 contained the 
lowest pathogen population. The results for inhibition of E. coli O157:H7 was 
different compared to L. monocytogenes and S. enterica, with regards to the protective 
culture showing the most significant potential. This may be due to the fact that E. coli 
O157:H7 is naturally more acid-resistant than the other two pathogens. Therefore, L. 
lactis AA4 is weaker in controlling E. coli O157:H7. The mechanism for the antibiosis 
of E. mundtii CUGF08 against E. coli O157:H7 must be different from that of L. lactis 
AA4. 
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Figure 5.3. Growth of E. coli O157:H7 on alfalfa sprouts inoculated with Lactococcus 
lactis AA4, Enterococcus mundtii CUGF08, both, and none (control). 
 
 
Growth of protective cultures on alfalfa sprouts. The growth curves of protective 
cultures on sprouts that were inoculated with L. monocytogenes, S. enterica or E. coli 
O157:H7 are similar and reported jointly. L. lactis AA4, either inoculated singly or 
with E. mundtii CUGF08, maintained a stable high population level during the entire 
sprouting process (Figure 5.4), suggesting it can establish on alfalfa sprouts very 
easily and compete with other native microbiota for growth and nutrients. Interestingly, 
single inoculation of E. mundtii CUGF08 onto alfalfa seeds promoted the growth of L. 
lactis subsp. lactis (Figure 5.4). Native L. lactis subsp. lactis strains grew rapidly to 4-
log CFU/g within 24 h and maintained the population steadily at approximately 5-log 
CFU/g. To exclude the possibility of contamination by L. lactis AA4, colonies on 
Alsan gar were randomly selected. PCR was performed to amplify their 16S rRNA 
gene to confirm that the L. lactis subsp. lactis on the non-AA4 inoculated sprouts were 
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not AA4 due to contamination. 16S rRNA gene sequencing and nucleotide homology 
analysis of selected colonies on Alsan agar revealed that the L. lactis subsp. lactis 
strains on Alsan agar were not L. lactis AA4. This implies that L. lactis subsp. lactis is 
an integral member of the native microbiota of alfalfa sprouts and E. mundtii CUGF08 
may function as a selection factor for L. lactis subsp. lactis to outgrow other species 
by mechanisms of acid production or other unknown factors. Without E. mundtii 
CUGF08 as a selective pressure or a growth-promoting factor, L. lactis subsp. lactis 
did not grow to detectable levels during 4 days of sprouting, as seen with the control. 
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Figure 5.4. Growth of L. lactis AA4 on Salmonella enterica-contaminated alfalfa 
sprouts inoculated with Lactococcus lactis AA4, Enterococcus mundtii CUGF08, both, 
and none (control). 
 
 
Unlike L. lactis AA4, E. mundtii CUGF08 did not maintain the level of inoculation 
to the end of sprouting when it was inoculated either singly or in combination with L. 
lactis AA4 (Figure 5.5). The level of E. mundtii CUGF08 gradually decreased by 1-
log in 4 days of sprouting. Unlike L. lactis subsp. lactis whose growth was promoted 
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by E. mundtii CUGF08, growth of Enterococcus spp. was not promoted by single 
inoculation of L. lactis AA4. This implies that Enterococcus spp. may not be a 
ubiquitous member of the native microbiota of alfalfa sprouts or that the selection 
factors provided by L. lactis AA4 does not support the growth of Enterococcus spp. 
This hypothesis was evidenced by the fact that the population of Enterococcus spp. on 
sprouts co-inoculated with L. lactis AA4 and E. mundtii CUGF08 was significantly 
lower than that of Enterococcus spp. on sprouts that were inoculated solely with E. 
mundtii CUGF08 (Figure 5.5). There was no detectable growth of Enterococcus spp. 
on sprouts without inoculation of protective cultures. 
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Figure 5.5. Growth of Enterococcus spp. on Salmonella enterica-contaminated alfalfa 
sprouts inoculated with Lactococcus lactis AA4, Enterococcus mundtii CUGF08, both, 
and none (control). 
 
In situ bacteriocin activity and pH of finished sprouts. There was no detectable 
bacteriocin activity of mundticin L or nisin Z in the finishing sprouts over the course 
of the sprouting process, as determined by the spot diffusion assay. However, this does 
not suggest that no bacteriocin was produced by the protective cultures since the 
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detection limit by the spot diffusion assay is not sufficiently sensitive. In addition, 
there could be many additional factors that influence the detection of bacteriocins, 
such as proteolytic enzymes in the samples that could have degraded bacteriocins prior 
to detection or interfering compounds contained in the sprout samples. The production 
of mundticin L should be constitutive due to the lack of three-component regulatory 
system in the genetic organization of mundticin L (7) although it was not detected in 
sprouts. Both mundticin L and nisin Z have little inhibitory activity against Gram-
negative pathogens but they may have been involved in control of L. monocytogenes 
that was observed in the inoculated bioprotective culture samples. 
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Figure 5.6. pH of finished sprouts contaminated with S. enterica, E. coli O157:H7 or L. 
monocytogenes and inoculated with L. lactis AA4, L. lactis AA4 and E. mundtii 
CUGF08, E. mundtii CUGF08 or no protective cultures (control). 
 
The pH of finished sprouts was influenced by protective cultures regardless of the 
pathogens for pre-inoculation (Figure 5.6). L. lactis AA4 inoculated alone or co-
inoculated with E. mundtii CUGF08 reduced the pH of sprouts to lower levels than the 
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samples inoculated with E. mundtii CUGF08 and the control. Sprouts without any 
inoculated protective cultures had highest pH. The pH of finished sprouts contributed 
at least partially to the difference in population of pathogens on sprouts while other 
factors that could be involved in antibiosis are largely unknown. 
We have shown that protective cultures may be used to significantly control the 
growth of pathogens on sprouts. Although protective cultures did not inhibit the 
growth of L. monocytogenes, S. enterica and E. coli O157:H7 completely, the 
inoculation levels of pathogens were artificially higher compared to the natural 
contamination levels which could be as low as 1-6 pathogens per 100 g of seeds (10). 
Studies are currently being performed to challenge alfalfa seeds with pathogens levels 
comparable to those observed in seeds that have been responsible for foodborne illness 
outbreaks. 
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CHAPTER 6 
DISCUSSION, CONCLUSIONS, AND PROSPECTUS 
 
DISCUSSION AND CONCLUSIONS 
Two bacteriocin-producing lactic acid bacteria (LAB) isolated from alfalfa sprouts 
were characterized. L. lactis AA4 produces nisin Z while E. mundtii CUGF08 
produces mundticin L, a newly identified class IIa bacteriocin that exhibits high 
antimicrobial activity against Listeria spp. and other genera (4). Mundticin L is 
composed of 43 amino acid with a YGNGX motif in its N-terminus. Unlike the 
homologous molecules such as mundticin ATO6/KS (1, 9) and enterocin CRL35 (11), 
the fifth amino acid of the YGNGX motif in mundticin L is leucine instead of valine. 
In addition, several different amino acids in the immunity protein and the ABC 
transporter make mundticin L a unique molecule. 
The genetic determinants consist of three genes organized in two operons. The first 
operon contains a single gene encoding the mundticin L prepeptide while the second 
operon contains two genes encoding the ABC transporter and the immunity protein. 
This type of genetic organization represented by mundticin L, ATO6/KS and enterocin 
CRL35 is unique compared to other class IIa bacteriocins. In most cases, the structural 
and immunity genes are clustered in the same operon. However, these genes for 
mundticins are organized separately in two operons. This raises a question as to how 
transcription of these two genes is coordinated to ensure sufficient immunity levels to 
the mundticin bacteriocins. 
Interestingly, the mundticin L producer was found to be deficient in immunity to its 
own bacteriocin as observed with agar diffusion assay. The gene for the immunity 
protein was heterologously expressed in sensitive strains to determine if this unusual 
phenotype was due to the function of its immunity protein. The expressed immunity 
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protein did not confer full protection to the sensitive strains, suggesting that the 
protein itself may not be sufficient for full immunity. Considering the fact that E. 
mundtii CUGF08 is able to grow to high cell density in liquid culture, additional 
unknown factors or additional immunity-related proteins might be involved in this 
phenotype. A genome-wide mutagenesis may elucidate the molecular mechanism or 
additional genes involved in this unusual immunity phenotype. 
Alfalfa sprouts are the most commonly associated type of sprouts for foodborne 
illness outbreaks. The second part of this study was to challenge artificially 
contaminated alfalfa seeds with intervention strategies that would decontaminate 
sprouting seeds regardless of seed surface structures such as crevices and wrinkles 
where pathogens may hide inside and become inaccessible to surface sanitizers (2).  
Mild heating and biocontrol using protective cultures are potential intervention 
methods. Unlike chemical sanitizers, mild heating can inactivate pathogens trapped in 
the seeds as well as pathogens on the surface. Mild heating has been shown to be 
effective in achieving 5-log reduction of S. enterica and E. coli O157:H7 on mung 
bean seeds (7). 5-log reduction of both pathogens on contaminated alfalfa seeds was 
observed in this study. The seeds can be treated at 55°C for up to 6 days without 
negatively affecting germination rates. However, alfalfa seeds can not tolerate more 
than 6 days of heating which results in decreased seed viability (germination) (3). 
Although mild heating was shown to be effective in achieving 5-log reduction in 
pathogens, post-processing contamination is still possible due to contaminated 
irrigation water and improper handling of seeds prior to sprouting or the finished 
sprouts. Food-grade lactic acid bacteria may be applied to alfalfa seeds to provide a 
sustainable antimicrobial hurdle not only prior to sprouting but also during the course 
of sprouting. Two bacteriocinogenic LAB strains isolated from alfalfa sprouts were 
studied for their bioprotective potential in enhancing the safety of contaminated alfalfa 
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seeds and sprouted seeds. Using LAB isolated from alfalfa sprouts has two advantages: 
it is more acceptable for consumers to include protective non-pathogenic cultures that 
are naturally occurring in sprouts; LAB from sprouts may be more adapted to the 
conditions in seeds and sprouts and have improved competitiveness with the rest of the 
sprout microbiota, compared to protective cultures from other non-sprout sources. 
Nisin Z and mundticin L represent class I and IIa bacteriocins, respectively. They 
are two bacteriocin groups that are considered to be the most promising for application 
in foods as a means to enhance the safety and extend shelf life. Although their 
antibiosis against Gram-negative pathogens such as S. enterica and E. coli O157:H7 is 
limited, nisin Z and mundticin L have a defined activity against L. monocytogenes. In 
addition, these two bacteriocins may affect the microbial ecology of the diverse 
background microorganisms and as a result, may have an impact on Gram-negative 
pathogens. Due to the beneficial properties of LAB as potential probiotics, the use of 
LAB as protective cultures in plant-based foods has attracted an abundance of 
scientific interest. Sprouted seeds are an excellent food for challenge studies with 
protective cultures considering the diverse microbiota and their rapid growth during 
sprouting which may serve as a model for application of LAB in other foods. 
In this study, both L. lactis AA4 and E. mundtii CUGF08 significantly controlled 
the growth of L. monocytogenes and S. enterica during sprouting. In general, L. lactis 
AA4 showed higher efficacy for the inhibition of L. monocytogenes and S. enterica 
compared to E. mundtii CUGF08. However, E. mundtii CUGF08 was more effective 
in controlling E. coli O157:H7 than L. lactis AA4. L. lactis is known as a strong acid 
producer compared to non-aciduric lactic acid bacteria that include Enterococcus spp. 
This was confirmed in these studies by the observed lower pH of finished sprouts 
inoculated with L. lactis AA4. However, E. coli O157:H7 is more acid resistant than S. 
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enterica and the mechanism of inhibition on E. coli O157:H7 by E. mundtii CUGF08 
may be less related to acid production.  
A significant synergistic effect of co-culture was not observed. Although both 
strains showed significant inhibition towards pathogens compared to the control 
(without protective cultures), pathogen growth was not completely controlled. This 
may be due to the fact that the inoculation level of pathogens on alfalfa seeds was 
artificially higher than that observed with “natural” contamination on commercial 
seeds. Studies are being performed to challenge alfalfa seeds inoculated with pathogen 
levels that are comparable to “natural” contamination levels. 
PROSPECTUS 
The author characterized the genetics and biochemical properties of mundticin L, a 
class IIa bacteriocin. The list of class IIa bacteriocins will continue to expand. This 
group of bacteriocins is the most promising after the approval of nisin by FDA as a 
food additive due to their high antimicrobial activity especially against L. 
monocytogenes, and stability over a wide range of pH and temperature conditions. 
Scientific efforts for the identification and characterization of new class IIa 
bacteriocins are ongoing. The relationship of bacteriocin structure and function along 
with their role in influencing complex microbial ecology will be an active area of 
research. 
With the cost of nucleotide sequencing decreasing and more genomes of LAB being 
sequenced, genomics will accelerate the discovery of new bacteriocins. Genomics as a 
tool to discover new bacteriocins has advantages over phenotypic observations. For 
example, bacteriocins whose production is conditional, due to the variation in 
sensitivity of indicator strains, may be revealed by genome data mining. Also, related 
genes are more readily to be identified. However, it is difficult to locate potential 
bacteriocin genes due to their relatively small molecular size on the genome. Although 
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previous data for reported bacteriocins may provide clues and prediction models to 
facilitate genome data mining and bacteriocin characterization (5, 6), discovery of new 
bacteriocins by genomics tools is limited due to the lack of a universal model for 
identification of bacteriocin gene clusters and accurate annotation (10, 12). Genomics 
will by no means replace phenotypic screening for new bacteriocins. 
In this study, an unusual phenotype of E. mundtii CUGF08 was observed. The 
mundticin L producer is deficient in immunity to its own bacteriocin as demonstrated 
by agar diffusion assay. This phenotype seems unique to E. mundtii strains producing 
mundticins. An investigation into the molecular mechanism of this unusual immunity 
phenotype may reveal new factors that have not been previously reported. 
  Two bacteriocinogenic LAB were studied for their potential as bioprotective cultures 
to enhance the safety of sprouts. They showed antibiosis against all three pathogens 
tested, although which LAB is more effective depends on the target pathogen of 
interest. Biological control of microorganisms on sprouted seeds is extremely 
challenging due to the growth-promoting environment and diverse microbiota that 
naturally exist on alfalfa seeds. Therefore, alfalfa sprouts may serve a model that could 
be used to determine the feasibility of protective cultures as a means to enhance the 
safety of other types of produce. This study suggests that biological control of 
pathogens may be an alternative strategy or at least an additional hurdle in 
combination with other decontamination methods. 
Microbiology is advancing from the era of unicellularity to “multicellularity” for the 
21
st
 century. Scientific evidence has shown that individual microorganisms are 
coordinated by signaling molecules just like constituent cells in a eukaryotic tissue. 
While signaling molecules are acyl homoserine lactones in Gram-negative bacteria, 
cell-to-cell interaction in Gram-positive bacteria is mediated by small peptides (8). 
Bacteriocins are amid the context of the typical ecology and may play an important 
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role in intra-species and even inter-species interactions. Given the diversity of the 
microbiota on alfalfa seeds, the antibiosis of protective cultures against other 
microorganisms may be a result of more complex undiscovered factors other than just 
acid production. Scientific advances in this area are essential in understanding the 
mechanisms and may promote application of bioprotective cultures in a more easily 
defined manner. 
With increasing market demand for minimally processed foods with “green” and 
“natural” preservatives, more studies will emerge in the area of bio-preservation using 
food-grade lactic acid bacteria that can protect foods from being contaminated while 
promote the health of consumers as probiotics. 
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